Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☑	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2023

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____to_____

Commission File No. 1-7604

Crown Crafts, Inc.

(Exact name of registrant as specified in its charter)

Delaware		58-0678148
(State or other jurisdiction of incorporation)		(I.R.S. Employer Identification No.)

916 South Burnside Avenue, Gonzales, LA		70737
(Address of principal executive offices)		(Zip Code)

(225) 647-9100

(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	CRWS	Nasdaq Capital Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-Accelerated filer	☑	Smaller Reporting Company	☑
		Emerging Growth Company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

The number of shares of common stock, $0.01 par value, of the registrant outstanding as of January 30, 2024 was 10,240,719.

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

CROWN CRAFTS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
DECEMBER 31, 2023 (UNAUDITED) AND APRIL 2, 2023
(amounts in thousands, except share and per share amounts)

	December 31, 2023			April 2, 2023

*ASSETS*
Current assets:
Cash and cash equivalents	$	683		$	1,742
Accounts receivable (net of allowances of $2,456 at December 31, 2023 and $1,474 at April 2, 2023):
Due from factor		17,636			20,740
Other		4,408			2,068
Inventories		34,935			34,211
Prepaid expenses		2,744			1,614
Total current assets		60,406			60,375

Operating lease right of use assets		15,813			17,305

Property, plant and equipment - at cost:
Vehicles		-			182
Leasehold improvements		480			473
Machinery and equipment		4,928			4,333
Furniture and fixtures		476			408
Property, plant and equipment - gross		5,884			5,396
Less accumulated depreciation		4,188			3,677
Property, plant and equipment - net		1,696			1,719

Finite-lived intangible assets - at cost:
Customer relationships		8,174			8,174
Other finite-lived intangible assets		4,766			4,766
Finite-lived intangible assets - gross		12,940			12,940
Less accumulated amortization		9,918			9,467
Finite-lived intangible assets - net		3,022			3,473

Goodwill		7,874			7,912
Deferred income taxes		291			-
Other		202			188
Total Assets	$	89,304		$	90,972

*LIABILITIES AND SHAREHOLDERS' EQUITY*
Current liabilities:
Accounts payable	$	7,508		$	7,548
Accrued wages and benefits		1,013			1,087
Accrued royalties		1,030			614
Dividends payable		833			815
Operating lease liabilities, current		3,480			2,427
Other accrued liabilities		766			566
Total current liabilities		14,630			13,057

Non-current liabilities:
Long-term debt		10,014			12,674
Deferred income taxes		-			815
Operating lease liabilities, noncurrent		13,056			14,889
Reserve for unrecognized tax liabilities		379			323
Total non-current liabilities		23,449			28,701

Shareholders' equity:
Common stock - $0.01 par value per share; Authorized 40,000,000 shares at December 31, 2023 and April 2, 2023; Issued 13,138,226 shares at December 31, 2023 and 13,051,814 shares at April 2, 2023		131			131
Additional paid-in capital		57,699			57,126
Treasury stock - at cost - 2,897,507 shares at December 31, 2023 and April 2, 2023		(15,821	)		(15,821	)
Retained Earnings		9,216			7,778
Total shareholders' equity		51,225			49,214
Total Liabilities and Shareholders' Equity	$	89,304		$	90,972

See notes to unaudited condensed consolidated financial statements.

CROWN CRAFTS, INC. AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME

THREE- AND NINE-MONTH PERIODS ENDED DECEMBER 31, 2023 AND JANUARY 1, 2023

(amounts in thousands, except per share amounts)


	Three-Month Periods Ended						Nine-Month Periods Ended
	December 31, 2023			January 1, 2023			December 31, 2023			January 1, 2023

Net sales	$	23,801		$	19,004		$	65,053		$	53,440
Cost of products sold		17,367			14,498			47,281			38,335
Gross profit		6,434			4,506			17,772			15,105
Marketing and administrative expenses		4,107			2,742			12,189			8,891
Income from operations		2,327			1,764			5,583			6,214
Other (expense) income:
Interest (expense) income - net of interest income		(208	)		5			(560	)		6
Gain on insurance proceeds received for damage to equipment		-			-			-			34
Gain on sale of property, plant and equipment		58			-			58			2
Other (expense) income - net		17			(1	)		(9	)		123
Income before income tax expense		2,194			1,768			5,072			6,379
Income tax expense		492			420			1,182			1,557
Net income	$	1,702		$	1,348		$	3,890		$	4,822

Weighted average shares outstanding:
Basic		10,241			10,118			10,198			10,096
Effect of dilutive securities		-			15			2			20
Diluted		10,241			10,133			10,200			10,116

Earnings per share - basic and diluted	$	0.17		$	0.13		$	0.38		$	0.48

See notes to unaudited condensed consolidated financial statements.

CROWN CRAFTS, INC. AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

THREE- AND NINE-MONTH PERIODS ENDED DECEMBER 31, 2023 AND JANUARY 1, 2023

	Common Shares				Treasury Shares						Additional					Total
	Number of Shares		Amount		Number of Shares			Amount			Paid-in Capital		Retained Earnings			Shareholders' Equity
	(Dollar amounts in thousands)

	Three-Month Periods
Balances - October 2, 2022		13,011,814	$	130		(2,894,242	)	$	(15,803	)	$	56,613	$	7,220		$	48,160

Stock-based compensation		-		-		-			-			253		-			253
Net income		-		-		-			-			-		1,348			1,348
Dividend declared on common stock - $0.08 per share		-		-		-			-			-		(809	)		(809	)

Balances - January 1, 2023		13,011,814	$	130		(2,894,242	)	$	(15,803	)	$	56,866	$	7,759		$	48,952

Balances - October 1, 2023		13,138,226	$	131		(2,897,507	)	$	(15,821	)	$	57,509	$	8,334		$	50,153

Stock-based compensation		-		-		-			-			190		-			190
Net income		-		-		-			-			-		1,702			1,702
Dividend declared on common stock - $0.08 per share		-		-		-			-			-		(820	)		(820	)

Balances - December 31, 2023		13,138,226	$	131		(2,897,507	)	$	(15,821	)	$	57,699	$	9,216		$	51,225

	Nine-Month Periods
Balances - April 3, 2022		12,944,918	$	129		(2,864,698	)	$	(15,614	)	$	55,925	$	5,361		$	45,801

Issuance of shares		66,896		1		-			-			97		-			98
Stock-based compensation		-		-		-			-			844		-			844
Acquisition of treasury stock		-		-		(29,544	)		(189	)		-		-			(189	)
Net income		-		-		-			-			-		4,822			4,822
Dividend declared on common stock - $0.24 per share		-		-		-			-			-		(2,424	)		(2,424	)

Balances - January 1, 2023		13,011,814	$	130		(2,894,242	)	$	(15,803	)	$	56,866	$	7,759		$	48,952

Balances - April 2, 2023		13,051,814	$	131		(2,897,507	)	$	(15,821	)	$	57,126	$	7,778		$	49,214

Issuance of shares		86,412		-		-			-			-		-			-
Stock-based compensation		-		-		-			-			573		-			573
Net income		-		-		-			-			-		3,890			3,890
Dividends declared on common stock - $0.24 per share		-		-		-			-			-		(2,452	)		(2,452	)

Balances - December 31, 2023		13,138,226	$	131		(2,897,507	)	$	(15,821	)	$	57,699	$	9,216		$	51,225

See notes to unaudited condensed consolidated financial statements.

CROWN CRAFTS, INC. AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

NINE-MONTH PERIODS ENDED DECEMBER 31, 2023 AND JANUARY 1, 2023

(amounts in thousands)

	Nine-Month Periods Ended
	December 31, 2023			January 1, 2023
Operating activities:
Net income	$	3,890		$	4,822
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation of property, plant and equipment		647			499
Amortization of intangibles		451			361
Amortization of right of use assets		3,208			1,330
Deferred income taxes		(1,106	)		195
Gain on insurance proceeds received for damage to equipment		-			(34	)
Gain on sale of property, plant and equipment		(58	)		(2	)
Reserve for unrecognized tax liabilities		56			98
Stock-based compensation		573			844
Changes in assets and liabilities:
Accounts receivable		765			4,352
Inventories		(1,112	)		(5,129	)
Prepaid expenses		(1,130	)		(470	)
Other assets		(14	)		2
Lease liabilities		(2,497	)		(1,461	)
Accounts payable		(113	)		(39	)
Accrued liabilities		542			(998	)
Net cash provided by operating activities		4,102			4,370
Cash used in investing activities:
Capital expenditures for property, plant and equipment		(662	)		(399	)
Insurance proceeds received for damage to equpment		-			34
Proceeds from sale of property, plant and equipment		105			2
Aggregate adjustment from the Manhattan and MTE acquisition		488			-
Net cash used in investing activities		(69	)		(363	)
Financing activities:
Repayments under revolving line of credit		(55,099	)		-
Borrowings under revolving line of credit		52,440			-
Purchase of treasury stock from related parties		-			(189	)
Issuance of common stock		-			98
Dividends paid		(2,433	)		(2,438	)
Net cash used in financing activities		(5,092	)		(2,529	)
Net (decrease) increase in cash and cash equivalents		(1,059	)		1,478
Cash and cash equivalents at beginning of period		1,742			1,598
Cash and cash equivalents at end of period	$	683		$	3,076

Supplemental cash flow information:
Income taxes paid	$	1,628		$	130
Interest paid		650			7

Noncash activities:
Property, plant and equipment purchased but unpaid		(9	)		(55	)
Dividends declared but unpaid		(833	)		(813	)

See notes to unaudited condensed consolidated financial statements.

CROWN CRAFTS, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE- AND NINE-MONTH PERIODS ENDED DECEMBER 31, 2023 AND JANUARY 1, 2023

Note 1 – Interim Financial Statements

Basis of Presentation: The accompanying unaudited condensed consolidated financial statements include the accounts of Crown Crafts, Inc. (the “Company”) and its subsidiaries and have been prepared pursuant to accounting principles generally accepted in the United States (“GAAP”) applicable to interim financial information as promulgated by the Financial Accounting Standards Board (“FASB”). Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. References herein to GAAP are to topics within the FASB Accounting Standards Codification (the “FASB ASC”), which the FASB periodically revises through the issuance of an Accounting Standards Update (“ASU”) and which has been established by the FASB as the authoritative source for GAAP recognized by the FASB to be applied by nongovernmental entities.

In the opinion of the Company’s management, the unaudited condensed consolidated financial statements contained herein include all adjustments necessary to present fairly the financial position of the Company as of December 31, 2023 and the results of its operations and cash flows for the periods presented. Such adjustments include normal, recurring accruals, as well as the elimination of all significant intercompany balances and transactions. Operating results for the three- and nine-months ended December 31, 2023 are not necessarily indicative of the results that may be expected by the Company for its fiscal year ending March 31, 2024. For further information, refer to the Company’s consolidated financial statements and notes thereto for the fiscal year ended April 2, 2023, included in the Company’s Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (the “SEC”).

Fiscal Year: The Company’s fiscal year ends on the Sunday that is nearest to or on March 31. References herein to “fiscal year 2024” or “2024” represent the 52-week period ending March 31, 2024 and references herein to “fiscal year 2023” or “2023” represent the 52-week period ended April 2, 2023.

Recently-Issued Accounting Standards: In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, the objective of which is to provide financial statement users with more information about the expected credit losses on financial instruments and other commitments to extend credit held by an entity. Current GAAP requires an “incurred loss” methodology for recognizing credit losses that delays recognition until it is probable that a loss has been incurred. Because this methodology restricted the recognition of credit losses that are expected, but did not yet meet the “probable” threshold, ASU No. 2016-13 was issued to require the consideration of a broader range of reasonable and supportable information when determining estimates of credit losses. The ASU is to be applied using a modified retrospective approach, and the ASU could have been early-adopted in the fiscal year that began after December 15, 2018. When issued, ASU No. 2016-13 was required to be adopted no later than the fiscal year beginning after December 15, 2019, but on November 15, 2019, the FASB issued ASU No. 2019-10, Financial Instruments – Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates, which provided for the deferral of the effective date of ASU No. 2016-13 for a registrant that is a smaller reporting company to the first interim period of the fiscal year beginning after December 15, 2022. Accordingly, the Company adopted ASU No. 2016-13 effective as of April 3, 2023. Because the Company assigns the majority of its trade accounts receivable under factoring agreements with The CIT Group/Commercial Services, Inc. (“CIT”), a subsidiary of CIT Group Inc., the adoption of the ASU has not had a significant impact on the Company’s financial position, results of operations and related disclosures.

In October 2023, the FASB issued ASU No. 2023-06, Disclosure Improvements – Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative, the objective of which is to clarify or improve disclosure and presentation requirements and to align the requirements in the FASB ASC with the SEC’s regulations. In August 2018, the SEC issued Release No. 33-10532, in which the SEC referred certain of its disclosure requirements that overlap with GAAP to the FASB for potential incorporation into the FASB ASC. The amendments in ASU No. 2023-06 are the result of the FASB’s decision to incorporate into the FASB ASC 14 of the 27 disclosures referred by the SEC. The FASB noted that the disclosure requirements in the SEC’s guidance and the FASB ASC should not be duplicated in both places. Accordingly, although the ASU was required to be adopted upon issuance, each amendment to the FASB ASC included in the ASU will not become effective until the effective date upon which the related SEC disclosure is no longer required. The amendments in this ASU are to be applied prospectively, and early application of the amendments is prohibited. The Company does not anticipate that the adoption of ASU No. 2023-06 will have a significant impact on the Company’s financial position, results of operations and related disclosures.

In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280) – Improvements to Reportable Segment Disclosures, the objective of which is to improve the disclosures about a public entity’s reportable segments by providing more detailed information about a reportable segment’s expenses. For disclosures associated with annual and interim periods, the amendments in ASU No. 2023-07 are required to be adopted for fiscal years beginning after December 15, 2023 and December 15, 2024, respectively, and early adoption is permitted. Upon adoption, a public entity must apply the amendments in ASU No. 2023-07 retrospectively to disclosures of all prior periods presented. The Company intends to adopt ASU No. 2023-07 effective as of April 1, 2024 and is evaluating the guidance of the ASU against its existing disclosures related to segment reporting.

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740) – Improvements to Income Tax Disclosures, the objective of which is to enhance the transparency and decision usefulness of income tax disclosures. The amendments in ASU No. 2023-09 are required to be adopted for fiscal years beginning after December 15, 2024 and early adoption is permitted. The Company is evaluating the guidance of the ASU No. 2023-09 against its existing disclosures related to income tax disclosures.

The Company has determined that all other ASUs issued which had become effective as of December 31, 2023, or which will become effective at some future date, are not expected to have a material impact on the Company’s consolidated financial statements.

Note 2 – Advertising Costs

The Company’s advertising costs are primarily associated with cooperative advertising arrangements with certain of the Company’s customers and are recognized using the straight-line method based upon aggregate annual estimated amounts for these customers, with periodic adjustments to the actual amounts of authorized agreements. Advertising expense is included in marketing and administrative expenses in the accompanying unaudited condensed consolidated statements of income and amounted to $267,000 and $123,000 for the three-month periods ended December 31, 2023 and January 1, 2023, respectively, and amounted to $631,000 and $370,000 for the nine-month periods ended December 31, 2023 and January 1, 2023, respectively.

Note 3 – Segment and Related Information

The Company operates primarily in one principal segment, infant, toddler and juvenile products. These products consist of infant and toddler bedding, blankets, accessories, bibs, toys and disposable products. Net sales of bedding, blankets and accessories and net sales of bibs, toys and disposable products for the three- and nine-month periods ended December 31, 2023 and January 1, 2023 are as follows (in thousands):

	Three-Month Periods Ended				Nine-Month Periods Ended
	December 31, 2023		January 1, 2023		December 31, 2023		January 1, 2023
Bedding, blankets and accessories	$	8,996	$	9,005	$	24,345	$	26,006
Bibs, toys and disposable products		14,805		9,999		40,708		27,434
Total net sales	$	23,801	$	19,004	$	65,053	$	53,440

Note 4 – Licensing Agreements

The Company has entered into licensing agreements that provide for royalty payments based on a percentage of sales with certain minimum guaranteed amounts. These royalty amounts are accrued based upon historical sales rates adjusted for current sales trends by customers. Royalty expense is included in cost of products sold in the accompanying unaudited consolidated statements of income and amounted to $1.3 million and $1.2 million for the three months ended December 31, 2023 and January 1, 2023, respectively, and amounted to $3.8 million and $3.5 million for the nine months ended December 31, 2023 and January 1, 2023, respectively.

Note 5 – Income Taxes

The Company files income tax returns in the many jurisdictions in which it operates, including the U.S., several U.S. states and the People’s Republic of China. The statute of limitations varies by jurisdiction; tax years open to examination or other adjustment as of December 31, 2023 were the fiscal years ended April 2, 2023, April 3, 2022, March 28, 2021, March 29, 2020 and March 31, 2019.

In August 2020, the Company was notified by the Franchise Tax Board of the State of California (the “FTB”) of its intention to examine the Company’s California income tax returns for the fiscal years ended April 2, 2017, April 1, 2018 and March 31, 2019. On May 30, 2023, the Company and the FTB entered into an agreement to settle (the “Settlement Agreement”) the FTB’s proposed assessment of additional income tax in respect of these consolidated income tax returns under examination for the amount of $442,000, which included interest expense of $86,000, payment of which was made by the Company to the FTB on May 31, 2023. Because the examination was ongoing as of April 2, 2023, and because the Settlement Agreement was entered into prior to the issuance of the consolidated financial statements as of and for the fiscal year ended April 2, 2023, the Company recorded the effect of the Settlement Agreement in the consolidated balance sheet as of April 2, 2023 and the consolidated statement of income for the fiscal year ended April 2, 2023.

Although management believes that the calculations and positions taken on its filed income tax returns are reasonable and justifiable, the outcome of an examination could result in an adjustment to the position that the Company took on such income tax returns. Such adjustment could also lead to adjustments to one or more other state income tax returns, or to income tax returns for subsequent fiscal years, or both. To the extent that the Company’s reserve for unrecognized tax liabilities is not adequate to support the cumulative effect of such adjustments, the Company could experience a material adverse impact on its future results of operations. Conversely, to the extent that the calculations and positions taken by the Company on the filed income tax returns under examination are sustained, the reversal of all or a portion of the Company’s reserve for unrecognized tax liabilities could result in a favorable impact on its future results of operations.

Note 6 – Inventories

As of December 31, 2023 and April 2, 2023, the Company’s balances of inventory were $34.9 million and $34.2 million, respectively, nearly all of which were finished goods.

Note 7 – Acquisition

On March 17, 2023 (the “Closing Date”), the Company acquired Manhattan Group, LLC (“Manhattan”) and Manhattan Toy Europe Limited (“MTE”), Manhattan’s wholly-owned subsidiary, from H Enterprises International, LLC (“HEI”) (the “Manhattan Acquisition”), for a purchase price of $17.0 million, subject to adjustments for cash at the Closing Date and to the extent that actual net working capital as of the Closing Date differed from target net working capital of $13.75 million (the “Aggregate Adjustment”). The Manhattan Acquisition was funded with cash available on the Closing Date and borrowings under the Company’s revolving line of credit with CIT. On September 29, 2023, the Company and HEI agreed to a settlement of the Aggregate Adjustment, pursuant to which HEI paid $509,000 to the Company, which included interest income of $21,000.

The Manhattan Acquisition was accounted for in accordance with FASB ASC Topic 805, Business Combinations. The Company is currently determining the allocation of the acquisition cost with the assistance of an independent third party. The identifiable assets acquired were recorded at their estimated fair value, which has been preliminarily determined based on available information and the use of multiple valuation approaches. The estimated useful lives of the identifiable intangible assets acquired were determined based upon the remaining time that these assets are expected to directly or indirectly contribute to the future cash flow of the Company. Certain data necessary to complete the acquisition cost allocation is not yet available, including the valuations of the assets acquired and liabilities assumed. The Company has not finalized its measurement of working capital items and goodwill.

The acquisition cost paid on the Closing Date amounted to $17.4 million, which included an estimate for cash as of the Closing Date and an estimate for the net working capital acquired. The settlement of the Aggregate Adjustment decreased the acquisition cost to $16.9 million. The following table represents the Company’s preliminary allocation of this acquisition cost (in thousands) to the identifiable assets acquired and the liabilities assumed based on their respective estimated fair values as of the Closing Date. The excess of the acquisition cost over the estimated fair value of the identifiable net assets acquired is reflected as goodwill.

Tangible assets:
Cash and cash equivalents	$	1,270
Accounts receivable		3,113
Inventories		12,578
Prepaid expenses		350
Other assets		91
Operating lease right of use assets		1,009
Property, plant and equipment		194
Total tangible assets		18,605
Amortizable intangible assets:
Tradename		300
Licensing relationships		200
Customer relationships		800
Total amortizable intangible assets		1,300
Goodwill		749
Total acquired assets		20,654

Liabilities assumed:
Accounts payable		2,048
Accrued wages and benefits		370
Operating lease liabilities, current		226
Other accrued liabilities		308
Operating lease liabilities, noncurrent		783
Total liabilities assumed		3,735
Net acquisition cost	$	16,919

The Company expects to complete the acquisition cost allocation during the 12-month period following the Closing Date, during which time the values of the assets acquired and liabilities assumed, including the goodwill, may need to be revised as appropriate. Based upon the preliminary allocation of the acquisition cost, the Company recognized $787,000 of goodwill as of the Closing Date, the entirety of which was assigned to the reporting unit of the Company that produces and markets infant and toddler bibs, developmental toys, feeding, bath care and disposable products, and the entirety of which is expected to be deductible for income tax purposes. The following table represents the adjustments made to the amount of goodwill during the nine-month period ended December 31, 2023.

Amount of goodwill recognized based upon the preliminary allocation of the acquisition cost	$	787,000
Adjustments made during the nine-month period ended December 31, 2023:
Settlement of the Aggregate Adjustment		(488,000	)
Resolution of pre-acquisition accounts receivable		(1,000	)
Revaluation of inventory as of the Closing Date		387,000
Resolution of pre-acquisition accounts payable		64,000
Net adjustments made during the nine-month period ended December 31, 2023		(38,000	)

Amount of goodwill recognized as of December 31, 2023	$	749,000

The Manhattan Acquisition resulted in net sales of $6.0 million and $14.5 million of developmental toy, feeding and baby care products for the three and nine months ended December 31, 2023, respectively. Manhattan recorded amortization expense associated with the acquired amortizable intangible assets of $32,000 and $90,000 during the three and nine months ended December 31, 2023, respectively, which is included in marketing and administrative expenses in the accompanying unaudited condensed consolidated statements of income. Amortization is computed using the straight-line method over the estimated useful lives of the assets, which are 15 years for the tradename, 10 years for the customer and licensing relationships and 11 years on a weighted-average basis for the grouping taken together.

The Company has determined, on a pro forma basis, that the combined net sales and the combined net income of the Company and Manhattan, giving effect to the Manhattan Acquisition as if it had been completed on April 4, 2022, would have been $26.0 million and $646,000, respectively, for the three months ended January 1, 2023, and would have been $74.5 million and $2.7 million, respectively, for the nine months ended January 1, 2023. The combined net income includes adjustments related to the amortization of the amortizable intangible assets acquired and estimates of the interest expense and income tax expense or benefit that would have been incurred, but otherwise do not reflect the costs of any integration activities or benefits that may result from the realization of future cost savings from operating efficiencies, or any revenue, tax or other synergies that may result from the Manhattan Acquisition.

Note 8 – Financing Arrangements

Factoring Agreements: To reduce its exposure to credit losses, the Company assigns the majority of its trade accounts receivable to CIT pursuant to factoring agreements, which have expiration dates that are coterminous with that of the financing agreement described below. Under the terms of the factoring agreements, CIT remits customer payments to the Company as such payments are received by CIT. As such, the Company does not take advances on the factoring agreements. CIT bears credit losses with respect to assigned accounts receivable from approved shipments, while the Company bears the responsibility for adjustments from customers related to returns, allowances, claims and discounts. CIT may at any time terminate or limit its approval of shipments to a particular customer. If such a termination or limitation occurs, then the Company either assumes (and may seek to mitigate) the credit risk for shipments to the customer after the date of such termination or limitation or discontinues shipments to the customer. Factoring fees, which are included in marketing and administrative expenses in the accompanying unaudited consolidated statements of income, amounted to $106,000 and $77,000 for the three months ended December 31, 2023 and January 1, 2023, respectively, and amounted to $265,000 and $224,000 for the nine months ended December 31, 2023 and January 1, 2023, respectively.

Credit Facility: The Company’s credit facility as of December 31, 2023 consisted of a revolving line of credit under a financing agreement with CIT of up to $35.0 million, which includes a $1.5 million sub-limit for letters of credit. The financing agreement matures on July 11, 2028, bears interest at prime minus 0.5% or the Secured Overnight Financing Rate (“SOFR”) plus 1.6%, and is secured by a first lien on all assets of the Company. At December 31, 2023, the Company had elected to pay interest on balances owed under the revolving line of credit under the SOFR option, which was 6.9%. The financing agreement also provides for the payment by CIT to the Company of interest at prime as of the beginning of the calendar month minus 2.0% on daily negative balances, if any, held at CIT.

At December 31, 2023 and April 2, 2023, the balances on the revolving line of credit were $10.0 million and $12.7 million, respectively, there was no letter of credit outstanding and $19.8 million and $20.0 million, respectively, was available under the revolving line of credit based on the Company’s eligible accounts receivable and inventory balances. The financing agreement contains usual and customary covenants for agreements of that type, including limitations on other indebtedness, liens, transfers of assets, investments and acquisitions, merger or consolidation transactions, transactions with affiliates, and changes in or amendments to the organizational documents for the Company and its subsidiaries. The Company believes it was in compliance with these covenants as of December 31, 2023.

Credit Concentration: The Company’s accounts receivable at December 31, 2023 amounted to $22.0 million, net of allowances of $2.5 million. Of this amount, $17.6 million was due from CIT under the factoring agreements, which represents the maximum loss that the Company could incur if CIT failed completely to perform its obligations under the factoring agreements. The Company’s accounts receivable at April 2, 2023 amounted to $22.8 million, net of allowances of $1.5 million. Of this amount, $20.7 million was due from CIT under the factoring agreements, which represented the maximum loss that the Company could have incurred if CIT had failed completely to perform its obligations under the factoring agreements.

Note 9 – Goodwill

Goodwill represents the excess of the purchase price over the fair value of net identifiable assets acquired in business combinations. For the purpose of presenting and measuring for the impairment of goodwill, the Company has two reporting units: one that produces and markets infant and toddler bedding, blankets and accessories and another that produces and markets infant and toddler bibs, toys and disposable products. The Company’s reporting units have recognized goodwill as of December 31, 2023 and April 2, 2023 of $30.8 million, which is reflected in the accompanying condensed consolidated balance sheets net of accumulated impairment charges of $22.9 million, for a net reported balance of $7.9 million.

The Company measures for impairment the goodwill within its reporting units annually as of the first day of the Company’s fiscal year. An additional interim measurement for impairment is performed during the year whenever an event or change in circumstances occurs that suggests that the fair value of either of the reporting units of the Company has more likely than not (defined as having a likelihood of greater than 50%) fallen below its carrying value. The annual or interim measurement for impairment is performed by first assessing qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If such qualitative factors so indicate, then the measurement for impairment is continued by calculating an estimate of the fair value of each reporting unit and comparing the estimated fair value to the carrying value of the reporting unit. If the carrying value exceeds the estimated fair value of the reporting unit, then an impairment charge is calculated as the difference between the carrying value of the reporting unit and its estimated fair value, not to exceed the goodwill of the reporting unit.

On April 3, 2023, the Company performed a qualitative assessment to determine if it is more likely than not that the fair values of the Company’s reporting units are less than their carrying values by evaluating relevant events and circumstances, including financial performance, market conditions and share price. Based on this assessment, the Company concluded that the goodwill for each of the Company’s reporting units was not considered at risk of impairment.

Note 10 – Other Intangible Assets

Other intangible assets as of December 31, 2023 and April 2, 2023 consisted primarily of the fair value of identifiable assets acquired in business combinations other than tangible assets and goodwill. The gross amount and accumulated amortization of the Company’s other intangible assets as of December 31, 2023 and April 2, 2023 and the amortization expense for the three- and nine-month periods ended December 31, 2023 and January 1, 2023, the entirety of which has been included in marketing and administrative expenses in the accompanying unaudited condensed consolidated statements of income, are as follows (in thousands):

									Amortization Expense
	Gross Amount				Accumulated Amortization				Three-Month Periods Ended				Nine-Month Periods Ended
	*December 31,*		*April 2,*		*December 31,*		*April 2,*		*December 31,*		*January 1,*		*December 31,*		*January 1,*
	*2023*		*2023*		*2023*		*2023*		*2023*		*2023*		*2023*		*2023*
Tradename and trademarks	$	2,867	$	2,867	$	2,145	$	2,025	$	42	$	35	$	120	$	105
Non-compete covenants		98		98		98		98		-		-		-		-
Patents		1,601		1,601		1,094		1,055		13		13		39		39
Customer relationships		8,174		8,174		6,566		6,289		92		72		277		217
Licensing relationships		200		200		15		-		5		-		15		-
Total other intangible assets	$	12,940	$	12,940	$	9,918	$	9,467	$	152	$	120	$	451	$	361

Note 11 – Leases

During the three- and nine-month periods ended December 31, 2023, the Company recognized operating lease obligations as right of use assets and recognized corresponding lease liabilities in the amount of $959,000, and entered into no such transactions during the three- and nine-month periods ended January 1, 2023. The Company made cash payments related to its recognized operating leases of $1.1 million and $492,000 during the three-month periods ended December 31, 2023 and January 1, 2023, respectively, and $2.5 million and $1.5 million for the nine-month periods ended December 31, 2023 and January 1, 2023, respectively. Such payments reduced the operating lease liabilities and were included in the cash flows provided by operating activities in the accompanying unaudited condensed consolidated statements of cash flows. The Company recognized noncash reductions to its operating right of use assets resulting from reductions to its lease liabilities in the amount of $254,000 and $16,000 during the three-month periods ended December 31, 2023 and January 1, 2023, respectively, and $757,000 and $59,000 during the nine-month periods ended December 31, 2023 and January 1, 2023, respectively. As of December 31, 2023 and April 2, 2023, the Company’s operating leases had weighted-average remaining lease terms of 4.2 years and 5.0 years, respectively, and weighted-average discount rates of 6.0% and 5.9%, respectively.

During the three- and nine-month periods ended December 31, 2023 and January 1, 2023, the Company classified its operating lease costs within the accompanying unaudited condensed consolidated statements of income as follows (in thousands):

	Three-Month Periods Ended				Nine-Month Periods Ended
	December 31, 2023		January 1, 2023		December 31, 2023		January 1, 2023
Cost of products sold	$	1,037	$	403	$	2,917	$	1,205
Marketing and administrative expenses		97		43		291		125
Total operating lease costs	$	1,134	$	446	$	3,208	$	1,330

The maturities of the Company’s operating lease liabilities as of December 31, 2023 are as follows (in thousands):

Fiscal Year
2024	$	1,073
2025		4,408
2026		4,510
2027		4,189
2028		3,952
2029		663
Total undiscounted operating lease payments		18,795
Less imputed interest		2,259
Operating lease liabilities - net	$	16,536

Note 12 – Stock-based Compensation

The Company has three incentive stock plans, the 2006 Omnibus Incentive Plan (the “2006 Plan”), the 2014 Omnibus Equity Compensation Plan (the “2014 Plan”) and the 2021 Incentive Plan (the “2021 Plan”), although grants may no longer be issued under either the 2006 Plan or the 2014 Plan. As of December 31, 2023, 549,000 shares of the Company’s common stock were available for future issuance under the 2021 Plan, which may be issued from authorized and unissued shares of the Company’s common stock or treasury shares. The Company recorded stock-based compensation expense of $190,000 and $253,000 during the three-month periods ended December 31, 2023 and January 1, 2023, respectively, and $573,000 and $844,000 during the nine-month periods ended December 31, 2023 and January 1, 2023, respectively. The Company records the compensation expense associated with stock-based awards granted to individuals in the same expense classifications as the cash compensation paid to those same individuals. No stock-based compensation costs were capitalized as part of the cost of an asset as of December 31, 2023.

Stock Options: The following table represents stock option activity for the nine-month periods ended December 31, 2023 and January 1, 2023:

	Nine-Month Periods Ended
	December 31, 2023					January 1, 2023
	Weighted-					Weighted-
	Average		Number of			Average		Number of
	Exercise		Options			Exercise		Options
	Price		Outstanding			Price		Outstanding
Outstanding at Beginning of Period	$	7.32		735,500		$	7.39		635,500
Granted		5.18		130,000			6.54		120,000
Exercised		-		-			4.92		(20,000	)
Expired		6.14		(10,000	)		-		-
Outstanding at End of Period		7.01		855,500			7.32		735,500
Exercisable at End of Period		7.41		665,500			7.42		499,000

As of December 31, 2023, the intrinsic value of the outstanding and exercisable stock options was $19,000 and $11,000, respectively. There were no stock options exercised during the nine months ended December 31, 2023 or the three months ended January 1, 2023. The intrinsic value of the stock options exercised during the nine months ended January 1, 2023 was $28,000. The Company received no cash from the stock options exercised during the nine months ended January 1, 2023. Upon the exercise of stock options, participants may choose to surrender to the Company those shares from the option exercise necessary to satisfy the exercise amount and their income tax withholding obligations that arise from the option exercise. The effect on the cash flow of the Company from these “cashless” option exercises is that the Company remits cash on behalf of the participant to satisfy his or her income tax withholding obligations. The Company used cash to remit the required income tax withholding amounts from “cashless” option exercises of $10,000 during the nine months ended January 1, 2023.

Stock-based compensation is calculated according to FASB ASC Topic 718, Compensation – Stock Compensation, which requires stock-based compensation to be accounted for using a fair-value-based measurement. To determine the estimated fair value of stock options granted, the Company uses the Black-Scholes-Merton valuation formula, which is a closed-form model that uses an equation to estimate fair value. The following table sets forth the assumptions used to determine the fair value of the non-qualified stock options that were awarded to certain employees during the nine months ended December 31, 2023 and January 1, 2023, which stock options vest over a two-year period, assuming continued service.

	Nine-Month Periods Ended
	December 31, 2023						January 1, 2023
Number of options issued		10,000			120,000			120,000
Grant date	November 14, 2023			June 21, 2023			June 7, 2022
Dividend yield		7.60	%		6.08	%		4.89	%
Expected volatility		20.00	%		25.00	%		30.00	%
Risk free interest rate		4.56	%		4.29	%		2.95	%
Contractual term (years)		10.00			10.00			10.00
Expected term (years)		3.00			3.00			4.00
Forfeiture rate		5.00	%		5.00	%		5.00	%
Exercise price (grant-date closing price) per option	$	4.21		$	5.26		$	6.54
Fair value per option	$	0.20		$	0.46		$	0.90

During the three- and nine-month periods ended December 31, 2023 and January 1, 2023, the Company classified its compensation expense associated with stock options within the accompanying unaudited condensed consolidated statements of income as follows (in thousands):

	Three-Month Period Ended December 31, 2023						Three-Month Period Ended January 1, 2023
	Cost of		Marketing &				Cost of		Marketing &
	Products		Administrative		Total		Products		Administrative		Total
Options Granted in Fiscal Year	Sold		Expenses		Expense		Sold		Expenses		Expense
2021	$	-	$	-	$	-	$	-	$	11	$	11
2022		-		-		-		9		20		29
2023		5		7		12		6		7		13
2024		3		4		7		-		-		-

Total stock option compensation	$	8	$	11	$	19	$	15	$	38	$	53

	Nine-Month Period Ended December 31, 2023						Nine-Month Period Ended January 1, 2023
	Cost of		Marketing &				Cost of		Marketing &
	Products		Administrative		Total		Products		Administrative		Total
Options Granted in Fiscal Year	Sold		Expenses		Expense		Sold		Expenses		Expense
2021	$	-	$	-	$	-	$	3	$	37	$	40
2022		10		21		31		31		66		97
2023		17		24		41		12		17		29
2024		6		8		14		-		-		-

Total stock option compensation	$	33	$	53	$	86	$	46	$	120	$	166

As of December 31, 2023, total unrecognized stock option compensation expense amounted to $69,000, which will be recognized as the underlying stock options vest over a weighted-average period of 9.9 months. The amount of future stock option compensation expense could be affected by any future stock option grants and by the separation from the Company of any individual who has received stock options that are unvested as of such individual’s separation date.

Non-vested Stock Granted to Directors: The following shares of non-vested stock were granted to the Company’s directors:

Number of Shares	Fair Value per Share		Grant Date	Vesting Period (Years)
60,412		$4.85	August 15, 2023	One
46,896		6.65	August 16, 2022	One
40,165		7.47	August 11, 2021	One
41,452		5.79	August 12, 2020	Two

The fair value of the non-vested stock granted to the Company’s directors was based on the closing price of the Company’s common stock on the date of each grant.

The non-vested stock granted on August 11, 2021 included 8,033 shares granted to E. Randall Chestnut, formerly the Company’s Chairman, President and Chief Executive Officer. On May 1, 2022, upon the resignation of Mr. Chestnut from the Board of Directors of the Company (the “Board”) and his retirement from all positions that he held within the Company, the vesting of these 8,033 shares was accelerated, with such shares having an aggregate value on such date of $50,000.

The non-vested stock granted on August 16, 2022 included 11,724 shares granted to Sidney Kirschner, a director of the Company since 2001. Upon the death of Mr. Kirschner on February 21, 2023, the vesting of these 11,724 shares was accelerated, with such shares having an aggregate value on such date of $67,000.

In August 2023 and August 2022, 35,172 shares and 52,856 shares, respectively, that had been granted to the Company’s directors vested, having an aggregate value of $168,000 and $331,000, respectively. The remaining shares set forth above will vest over the periods indicated, assuming continued service.

Non-vested Stock Granted to Employees: The following shares of non-vested stock were granted to certain of the Company’s employees:

Number of Shares	Fair Value per Share		Grant Date	Vesting Date
26,000		$4.77	August 14, 2023	August 14, 2024
40,000		5.85	March 21, 2023	March 21, 2025
25,000		7.98	June 9, 2021	June 9, 2022
10,000		7.60	February 22, 2021	February 22, 2023
20,000		4.92	June 10, 2020	June 10, 2022

These shares vest on the dates indicated, assuming continued service. In June 2022, 45,000 shares that had been granted to certain of the Company’s employees vested, having an aggregate value on their respective vesting dates of $293,000.

Performance Award Shares: On March 1, 2022, performance awards were granted to certain of the Company’s executive officers, consisting of 187,500 shares of the Company’s common stock, of which: (a) 75,000 shares shall be earned if the closing price per share of the Company’s common stock equals or exceeds $8.00 on ten trading days within any period of twenty consecutive trading days prior to March 1, 2027; and (b) 112,500 shares shall be earned if the closing price per share of the Company’s common stock equals or exceeds $9.00 on ten trading days within any period of twenty consecutive trading days prior to March 1, 2027. Upon the achievement of each applicable stock hurdle described above: (i) one-third of the shares that are earned shall vest on the date on which the shares are earned; (ii) one-third of the shares that are earned shall vest on the first anniversary of the date on which the shares are earned; and (iii) one-third shall vest on the second anniversary of the date on which the shares are earned. All shares that are non-earned or non-vested will be forfeited upon the termination of service. The Company, with the assistance of an independent third party, determined that the grant date fair value of the awards amounted to $732,000.

During the three- and nine-month periods ended December 31, 2023 and January 1, 2023, the Company recorded compensation expense associated with stock grants, which is included in marketing and administrative expenses in the accompanying unaudited condensed consolidated statements of income, as follows (in thousands):

	Three-Month Periods Ended				Nine-Month Periods Ended
Stock Granted in Fiscal Year	December 31, 2023		January 1, 2023		December 31, 2023		January 1, 2023
2021	$	-	$	9	$	-	$	76
2022		37		113		147		472
2023		23		78		160		130
2024		111		-		180		-

Total stock grant compensation	$	171	$	200	$	487	$	678

As of December 31, 2023, total unrecognized compensation expense related to the Company’s non-vested stock grants amounted to $491,000, which will be recognized over the respective vesting terms associated with each block of non-vested stock indicated above, such grants having an aggregate weighted-average vesting term of 6.8 months. The amount of future compensation expense related to the Company’s non-vested stock grants could be affected by any future non-vested stock grants and by the separation from the Company of any individual who has non-vested stock grants as of such individual’s separation date.

Note 13 – Subsequent Events

The Company has evaluated all other events which have occurred between December 31, 2023 and the date that the accompanying unaudited condensed consolidated financial statements were issued, and has determined that there are no material subsequent events that require disclosure.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

FORWARD-LOOKING INFORMATION

Certain of the statements made in this Quarterly Report on Form 10-Q (this “Quarterly Report”) within this Item 2. and elsewhere, including information incorporated herein by reference to other documents, are “forward-looking statements” within the meaning of, and subject to the protections of, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the Private Securities Litigation Reform Act of 1995. Such statements are based upon management’s current expectations, projections, estimates and assumptions. Words such as “expects,” “believes,” “anticipates,” “estimates,” “predicts,” “forecasts,” “plans,” “projects,” “targets,” “should,” “potential,” “continue,” “aims,” “intends,” “may,” “will,” “could,” “would” and variations of such words and similar expressions may identify such forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties that may cause future results to differ materially from those suggested by the forward-looking statements. These risks include, among others, general economic conditions, including changes in interest rates, in the overall level of consumer spending and in the price of oil, cotton and other raw materials used in the Company’s products, changing competition, changes in the retail environment, the Company’s ability to successfully integrate newly acquired businesses, the level and pricing of future orders from the Company’s customers, the Company’s dependence upon third-party suppliers, including some located in foreign countries with unstable political situations, the Company’s ability to successfully implement new information technologies, customer acceptance of both new designs and newly-introduced product lines, actions of competitors that may impact the Company’s business, disruptions to transportation systems or shipping lanes used by the Company or its suppliers, and the Company’s dependence upon licenses from third parties. Reference is also made to the Company’s periodic filings with the SEC for additional factors that may impact the Company’s results of operations and financial condition. The Company does not undertake to update the forward-looking statements contained herein to conform to actual results or changes in the Company’s expectations, whether as a result of new information, future events or otherwise.

DESCRIPTION OF BUSINESS

The Company was originally formed as a Georgia corporation in 1957 and was reincorporated as a Delaware corporation in 2003. The Company operates indirectly through its four wholly-owned subsidiaries, NoJo Baby & Kids, Inc., Sassy Baby, Inc., Manhattan and MTE in the infant, toddler and juvenile products segment within the consumer products industry. The infant, toddler and juvenile products segment consists of infant and toddler bedding and blankets, bibs, disposables, toys and feeding products.

The Company’s products are marketed under Company-owned trademarks, under trademarks licensed from others and as private label goods. Sales of the Company’s products are made directly to retailers, such as mass merchants, large chain stores, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, wholesale clubs and internet-based retailers.

The infant, toddler and juvenile consumer products industry is highly competitive. The Company competes with a variety of distributors and manufacturers (both branded and private label), including large infant, toddler and juvenile product companies and specialty infant, toddler and juvenile product manufacturers, on the basis of quality, design, price, brand name recognition, service and packaging. The Company’s ability to compete depends principally on styling, price, service to the retailer and continued high regard for the Company’s products and trade names.

Foreign and domestic contract manufacturers produce most of the Company’s products, with the largest concentration being in China. The Company makes sourcing decisions based on quality, timeliness of delivery and price, including the impact of ocean freight and duties. Although the Company maintains relationships with a limited number of suppliers, the Company believes that its products may be readily manufactured by several alternative sources in quantities sufficient to meet the Company's requirements.

The Company’s products are warehoused and distributed domestically from leased facilities located in Compton, California and Eden Valley, Minnesota and internationally from third-party logistics warehouses in Belgium and England.

A summary of certain factors that management considers important in reviewing the Company’s results of operations, financial position, liquidity and capital resources is set forth below, which should be read in conjunction with the accompanying condensed consolidated financial statements and related notes included in the preceding sections of this Quarterly Report.

RESULTS OF OPERATIONS

The following table contains the results of operations for the three- and nine-month periods ended December 31, 2023 and January 1, 2023 and the dollar and percentage changes for those periods (in thousands, except percentages):

	Three-Month Periods Ended						Change						Nine-Month Periods Ended						Change
	December 31, 2023			January 1, 2023			$			%			December 31, 2023			January 1, 2023			$			%
Net sales by category:
Bedding, blankets and accessories	$	8,996		$	9,005		$	(9	)		-0.1	%	$	24,345		$	26,006		$	(1,661	)		-6.4	%
Bibs, toys and disposable products		14,805			9,999			4,806			48.1	%		40,708			27,434			13,274			48.4	%
Total net sales		23,801			19,004			4,797			25.2	%		65,053			53,440			11,613			21.7	%
Cost of products sold		17,367			14,498			2,869			19.8	%		47,281			38,335			8,946			23.3	%
Gross profit		6,434			4,506			1,928			42.8	%		17,772			15,105			2,667			17.7	%
% of net sales		27.0	%		23.7	%								27.3	%		28.3	%
Marketing and administrative expenses		4,107			2,742			1,365			49.8	%		12,189			8,891			3,298			37.1	%
% of net sales		17.3	%		14.4	%								18.7	%		16.6	%
Interest (expense) income - net		(208	)		5			(213	)		-4260.0	%		(560	)		6			(566	)		-9433.3	%
Other (expense) income - net		75			(1	)		76			-7600.0	%		49			159			(110	)		-69.2	%
Income tax expense		492			420			72			17.1	%		1,182			1,557			(375	)		-24.1	%
Net income		1,702			1,348			354			26.3	%		3,890			4,822			(932	)		-19.3	%
% of net sales		7.2	%		7.1	%								6.0	%		9.0	%

Net Sales: Sales increased to $23.8 million for the three months ended December 31, 2023, compared with $19.0 million for the three months ended January 1, 2023, an increase of $4.8 million, or 25.2%. Sales of bedding, blankets and accessories decreased by $9,000, and sales of bibs, toys and disposable products increased by $4.8 million. Although Manhattan generated net sales of $6.0 million of developmental toy, feeding and baby care products during the current year quarter, cost pressures facing consumers continue to curb sales even as overall inflation has trended lower in recent months.

Sales increased to $65.1 million for the nine-month period ended December 31, 2023, compared with $53.4 million for the nine-month period ended January 1, 2023, an increase of $11.6 million, or 21.7%. Sales of bibs, toys and disposable products increased by $14.5 million due to the Manhattan Acquisition. This increase was offset by lower sales of bedding, blankets and accessories, which decreased by $1.7 million, due to the continued impact of retailers that have been managing inventory levels, consumers that have lowered their spending due to inflationary pressures and continued overall softness in the infant and toddler bedding and blankets market.

Gross Profit: Manhattan contributed $1.1 million to the $1.9 million increase in gross profit for the three-month period ended December 31, 2023, as compared with the three-month period ended January 1, 2023. Gross profit as a percentage of net sales increased from 23.7% in the prior year quarter to 27.0% in the current year quarter.

Gross profit increased in amount by $2.7 million, but decreased from 28.3% of net sales for the nine-month period ended January 1, 2023 to 27.3% of net sales for the nine-month period ended December 31, 2023. Manhattan contributed $3.4 million to the increase, which was partially offset by an increase in operating lease costs in the current-year period, including $481,000 in operating lease costs of Manhattan.

Marketing and Administrative Expenses: Marketing and administrative expenses increased by $1.4 million, and increased from 14.4% of net sales for the three-month period ended January 1, 2023 to 17.3% of net sales for the three-month period ended December 31, 2023. The increases in the current-year period consisted primarily of $1.3 million for charges incurred by Manhattan and MTE.

Marketing and administrative expenses for the nine-month period ended December 31, 2023 increased by $3.3 million as compared with the nine-month period ended January 1, 2023, and increased from 16.6% of net sales for the year-to-date period of the prior year to 18.7% for the current-year period. The increases in the current-year period were the result of $3.3 million for charges incurred by Manhattan and MTE.

Income Tax Expense: The Company’s provision for income taxes is based upon an estimated annual effective tax rate (“ETR”) from continuing operations of 21.4% for the nine-month period ended December 31, 2023, as compared with an estimated annual ETR from continuing operations of 23.3% for the nine-month period ended January 1, 2023.

As a result of the consideration of the relevant information regarding the state portion of its income tax provision, the Company recorded discrete reserves for unrecognized tax liabilities of $9,000 and $12,000 during the three-month periods ended December 31, 2023 and January 1, 2023, respectively, and $34,000 and $58,000 during the nine-month periods ended December 31, 2023 and January 1, 2023, respectively, in the unaudited condensed consolidated statements of income. The Company also recorded discrete income tax charges of $43,000 and $6,000 during the nine months ended December 31, 2023 and January 1, 2023, respectively, to reflect the net effects of the excess tax benefits and tax shortfalls arising from the exercise and expiration of stock options and the vesting of non-vested stock.

The ETR on continuing operations and the discrete income tax charges and benefits set forth above resulted in an overall provision for income taxes of 23.3% and 24.4% for the nine-month periods ended December 31, 2023 and January 1, 2023, respectively.

Although the Company does not anticipate a material change to the ETR from continuing operations for the remainder of fiscal year 2024, several factors could impact the ETR, including variations from the Company’s estimates of the amount and source of its pre-tax income, and the actual ETR for the year could differ materially from the Company’s estimates.

FINANCIAL POSITION, LIQUIDITY AND CAPITAL RESOURCES

Net cash provided by operating activities decreased from $4.4 million for the nine-month period ended January 1, 2023 to $4.1 million for the nine-month period ended December 31, 2023. The decrease in the current year was partially the result of an increase in inventory in the current year that was $4.0 million lower than the increase in the prior year. This increase was partially offset by a decrease in accounts receivable in the current year that was $3.6 million lower than the decrease in the prior year.

Net cash used in investing activities decreased from $363,000 in the prior year to $69,000 in the current year. In the current-year period, the Company received $488,000 from the settlement of the Aggregate Adjustment from the Manhattan Acquisition, which was offset by an increase in the current year of $263,000 in capital expenditures for property, plant and equipment.

Net cash used in financing activities, which were primarily associated with net repayments under the revolving line of credit, increased by $2.6 million from the prior year to the current year.

As of December 31, 2023, the balance on the revolving line of credit was $10.0 million, there was no letter of credit outstanding and $19.8 million was available under the revolving line of credit based on the Company’s eligible accounts receivable and inventory balances.

To reduce its exposure to credit losses and to enhance the predictability of its cash flow, the Company assigns the majority of its trade accounts receivable to CIT under factoring agreements. Under the terms of the factoring agreements, CIT remits customer payments to the Company as such payments are received by CIT. As such, the Company does not take advances on the factoring agreements.

CIT bears credit losses with respect to assigned accounts receivable from approved shipments, while the Company bears the responsibility for adjustments from customers related to returns, allowances, claims and discounts. CIT may at any time terminate or limit its approval of shipments to a particular customer. If such a termination or limitation occurs, then the Company either assumes (and may seek to mitigate) the credit risk for shipments to the customer after the date of such termination or limitation or discontinues shipments to the customer. Factoring fees, which are included in marketing and administrative expenses in the accompanying unaudited consolidated statements of income, amounted to $106,000 and $77,000 for the three months ended December 31, 2023 and January 1, 2023, respectively, and amounted to $265,000 and $224,000 for the nine months ended December 31, 2023 and January 1, 2023, respectively.

The Company’s future performance is, to a certain extent, subject to general economic, financial, competitive, legislative, regulatory and other factors beyond its control. Based upon the current level of operations, the Company believes that its cash flow from operations and funds available under the revolving line of credit will be adequate to meet its liquidity needs.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

For a discussion of market risks that could affect the Company, refer to the risk factors disclosed in Item 1A. of Part 1 of the Company’s Annual Report on Form 10-K for the year ended April 2, 2023.

INTEREST RATE RISK

As of December 31, 2023, the Company had $10.0 million of indebtedness that bears interest at a variable rate, comprised of borrowings under the revolving line of credit. Based upon this level of outstanding debt, the Company’s annual net income would decrease by approximately $79,000 for each increase of one percentage point in the interest rate applicable to the debt.

COMMODITY RATE RISK

The Company sources its products primarily from foreign contract manufacturers, with the largest concentration being in China. The Company’s exposure to commodity price risk primarily relates to changes in the prices in China of cotton, oil and labor, which are the principal inputs used in a substantial number of the Company’s products. In addition, although the Company pays its Chinese suppliers in U.S. dollars, a strengthening of the rate of the Chinese currency versus the U.S. dollar could result in an increase in the cost of the Company’s finished goods. There is no assurance that the Company could timely respond to such increases by proportionately increasing the prices at which its products are sold to the Company’s customers.

MARKET CONCENTRATION RISK

The Company’s financial results are closely tied to sales to its top two customers, which represented approximately 71% of the Company’s gross sales in fiscal year 2023. In addition, 40% of the Company’s gross sales in fiscal year 2023 consisted of licensed products, which included 29% of sales associated with the Company’s license agreements with affiliated companies of the Walt Disney Company (“Disney”). As of January 30, 2024, three of the license agreements with Disney that expired on December 31, 2023 were renewed. With regard to the one license agreement that had not yet been renewed as of that date, the Company and Disney agreed to continue to operate under the terms of the expired license agreement. The Company’s results could be materially impacted by the loss of one or more of these licenses.

ITEM 4. CONTROLS AND PROCEDURES

The Company’s Chief Executive Officer and Chief Financial Officer have evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this Quarterly Report, as required by paragraph (b) of Rules 13a-15 or 15d-15 of the Exchange Act. Based on such evaluation, such officers have concluded that, as of the end of the period covered by this Quarterly Report, the Company’s disclosure controls and procedures are effective.

During the three-month period ended December 31, 2023, there were no changes in the Company’s internal control over financial reporting (“ICFR”) identified in connection with the evaluation required by paragraph (d) of Rules 13a-15 or 15d-15 of the Exchange Act that has materially affected, or is reasonably likely to materially affect, the Company’s ICFR.

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

The Company is, from time to time, involved in various legal and regulatory proceedings relating to claims arising in the ordinary course of its business. Neither the Company nor any of its subsidiaries is a party to any such proceeding the outcome of which, individually or in the aggregate, is expected to have a material adverse effect on the Company’s financial condition, results of operations or cash flow.

ITEM 1A. RISK FACTORS

There have been no material changes to the risk factors disclosed in Item 1A of Part 1 of the Company’s Annual Report on Form 10-K for the year ended April 2, 2023.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

During the three-month period ended December 31, 2023, none of the Company’s directors or officers informed the Company of the adoption, modification or termination of a “Rule 10-b5-1 trading arrangement” or “non-Rule 10-b5-1 trading arrangement,” as those terms are defined in Item 408(a) of Regulation S-K.

ITEM 6. EXHIBITS

Exhibits required to be filed by Item 601 of Regulation S-K are included as Exhibits to this Quarterly Report as follows:

Exhibit Number		Description of Exhibit

2.1		Letter Agreement dated as of July 28, 2023 between the Company and H Enterprises International, LLC (“HEI”). (3)

2.2		Letter Agreement dated as of September 15, 2023 between the Company and HEI. (4)

2.3		Letter Agreement dated September 29, 2023 between the Company and HEI. * (5)

3.1		Amended and Restated Certificate of Incorporation of the Company. (1)

3.2		Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company. (2)

3.3		Amended and Restated Bylaws of the Company, effective as of November 14, 2023. (6)

31.1		Rule 13a-14(a)/15d-14(a) Certification by the Company’s Chief Executive Officer. (7)

31.2		Rule 13a-14(a)/15d-14(a) Certification by the Company’s Chief Financial Officer. (7)

32.1		Section 1350 Certification by the Company’s Chief Executive Officer. (7)

32.2		Section 1350 Certification by the Company’s Chief Financial Officer. (7)

101		Interactive data files pursuant to Rule 405 of SEC Regulation S-T in connection with registrant’s Form 10-Q for the quarterly period ended December 31, 2023, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) Unaudited Condensed Consolidated Balance Sheets; (ii) Unaudited Condensed Consolidated Statements of Income; (iii) Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Equity; (iv) Unaudited Condensed Consolidated Statements of Cash Flows; and (v) Notes to Unaudited Condensed Consolidated Financial Statements.

104		Cover page Interactive Data File pursuant to Rule 406 of SEC Regulation S-T formatted in iXBRL (Inline eXtensible Business Reporting Language) and contained in Exhibit 101.

Certain schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company agrees to furnish supplementally to the SEC a copy of any omitted schedules upon request; provided, however, that the Company may request confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

(1)

Incorporated herein by reference to Exhibit 3.1 to the registrant’s Quarterly Report on Form 10-Q for the quarter ended December 28, 2003.

(2)

Incorporated herein by reference to Exhibit 3.1 to the registrant’s Current Report on Form 8-K dated August 9, 2011.

(3)

Incorporated herein by reference to Exhibit 2.1 to the registrant’s Quarterly Report on Form 10-Q for the quarter ended October 1, 2023.

(4)

Incorporated herein by reference to Exhibit 2.2 to the registrant’s Quarterly Report on Form 10-Q for the quarter ended October 1, 2023.

(5)

Incorporated herein by reference to Exhibit 2.3 to the registrant’s Quarterly Report on Form 10-Q for the quarter ended October 1, 2023.

(6)

Incorporated herein by reference to Exhibit 3.3 to the registrant’s Quarterly Report on Form 10-Q for the quarter ended October 1, 2023.

(7)

Filed herewith.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	CROWN CRAFTS, INC.

Date: February 14, 2024	/s/ Craig J. Demarest
	CRAIG J. DEMAREST Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

Exhibit 31.1

CERTIFICATION

I, Olivia W. Elliott, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Crown Crafts, Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: February 14, 2024	/s/ Olivia W. Elliott
	Olivia W. Elliott, President and Chief Executive Officer, Crown Crafts, Inc.

^{Exhibit 31.2}

CERTIFICATION

I, Craig J. Demarest, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Crown Crafts, Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(a)

(b)

(c)

(d)

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 14, 2024

/s/ Craig J. Demarest

Craig J. Demarest,

Vice President and Chief Financial Officer,

Crown Crafts, Inc.

Exhibit 32.1

SECTION 1350 CERTIFICATION

I, Olivia W. Elliott, the President and Chief Executive Officer of Crown Crafts, Inc. (the “Company”), do hereby certify, in accordance with 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

1.	The Quarterly Report on Form 10-Q of the Company for the period ended December 31, 2023 (the “Periodic Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2.	The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: February 14, 2024

/s/ Olivia W. Elliott

Olivia W. Elliott,

President and Chief Executive Officer,

Crown Crafts, Inc.

Exhibit 32.2

SECTION 1350 CERTIFICATION

I, Craig J. Demarest, a Vice President and the Chief Financial Officer of Crown Crafts, Inc. (the “Company”), do hereby certify, in accordance with 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

1.	The Quarterly Report on Form 10-Q of the Company for the period ended December 31, 2023 (the “Periodic Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2.	The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: February 14, 2024

/s/ Craig J. Demarest

Craig J. Demarest,

Vice President and Chief Financial Officer,

Crown Crafts, Inc.

Document And Entity Information - shares	9 Months Ended
Document And Entity Information - shares	Dec. 31, 2023	Jan. 30, 2024
Document Information [Line Items]
Entity Central Index Key	0000025895
Entity Registrant Name	CROWN CRAFTS INC
Amendment Flag	false
Current Fiscal Year End Date	--03-31
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2024
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 31, 2023
Document Transition Report	false
Entity File Number	1-7604
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	58-0678148
Entity Address, Address Line One	916 South Burnside Avenue
Entity Address, City or Town	Gonzales
Entity Address, State or Province	LA
Entity Address, Postal Zip Code	70737
City Area Code	225
Local Phone Number	647-9100
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	CRWS
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		10,240,719

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Dec. 31, 2023	Apr. 02, 2023
Current assets:
Cash and cash equivalents	$ 683	$ 1,742
Accounts receivable (net of allowances of $2,456 at December 31, 2023 and $1,474 at April 2, 2023):
Due from factor	17,636	20,740
Other	4,408	2,068
Inventory, Net	34,935	34,211
Prepaid expenses	2,744	1,614
Total current assets	60,406	60,375
Operating lease right of use assets	15,813	17,305
Property, plant and equipment - at cost:
Vehicles	0	182
Leasehold improvements	480	473
Machinery and equipment	4,928	4,333
Furniture and fixtures	476	408
Property, plant and equipment - gross	5,884	5,396
Less accumulated depreciation	4,188	3,677
Property, plant and equipment - net	1,696	1,719
Finite-lived intangible assets - at cost:
Customer relationships	8,174	8,174
Other finite-lived intangible assets	4,766	4,766
Finite-lived intangible assets - gross	12,940	12,940
Less accumulated amortization	9,918	9,467
Finite-lived intangible assets - net	3,022	3,473
Goodwill	7,874	7,912
Deferred income taxes	291	0
Other	202	188
Total Assets	89,304	90,972
Current liabilities:
Accounts payable	7,508	7,548
Accrued wages and benefits	1,013	1,087
Accrued royalties	1,030	614
Dividends payable	833	815
Operating lease liabilities, current	3,480	2,427
Other accrued liabilities	766	566
Total current liabilities	14,630	13,057
Non-current liabilities:
Long-term debt	10,014	12,674
Deferred income taxes	0	815
Operating lease liabilities, noncurrent	13,056	14,889
Reserve for unrecognized tax liabilities	379	323
Total non-current liabilities	23,449	28,701
Shareholders' equity:
Common stock - $0.01 par value per share; Authorized 40,000,000 shares at December 31, 2023 and April 2, 2023; Issued 13,138,226 shares at December 31, 2023 and 13,051,814 shares at April 2, 2023	131	131
Additional paid-in capital	57,699	57,126
Treasury stock - at cost - 2,897,507 shares at December 31, 2023 and April 2, 2023	(15,821)	(15,821)
Retained Earnings	9,216	7,778
Total shareholders' equity	51,225	49,214
Total Liabilities and Shareholders' Equity	$ 89,304	$ 90,972

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) $ in Thousands	Dec. 31, 2023	Apr. 02, 2023
Allowance for doubtful accounts receivable	$ 2,456	$ 1,474
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	40,000,000	40,000,000
Common stock, shares issued (in shares)	13,138,226	13,051,814
Treasury stock, shares (in shares)	2,897,507	2,897,507

Unaudited Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Jan. 01, 2023	Dec. 31, 2023	Jan. 01, 2023
Net sales	$ 23,801	$ 19,004	$ 65,053	$ 53,440
Cost of products sold	17,367	14,498	47,281	38,335
Gross profit	6,434	4,506	17,772	15,105
Marketing and administrative expenses	4,107	2,742	12,189	8,891
Income from operations	2,327	1,764	5,583	6,214
Other (expense) income:
Interest (expense) income - net of interest income	(208)	5	(560)	6
Gain on insurance proceeds received for damage to equipment	0	0	0	34
Gain on sale of property, plant and equipment	58	0	58	2
Other (expense) income - net	17	(1)	(9)	123
Income before income tax expense	2,194	1,768	5,072	6,379
Income tax expense	492	420	1,182	1,557
Net income	$ 1,702	$ 1,348	$ 3,890	$ 4,822
Weighted average shares outstanding:
Basic (in shares)	10,241	10,118	10,198	10,096
Effect of dilutive securities (in shares)	0	15	2	20
Diluted (in shares)	10,241	10,133	10,200	10,116
Earnings per share - basic and diluted (in dollars per share)	$ 0.17	$ 0.13	$ 0.38	$ 0.48

Unaudited Condensed Consolidated Statements of Changes In Shareholders' Equity - USD ($) $ in Thousands	Common Stock [Member]	Treasury Stock, Common [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balances (in shares) at Apr. 03, 2022	12,944,918	(2,864,698)
Balances at Apr. 03, 2022	$ 129	$ (15,614)	$ 55,925	$ 5,361	$ 45,801
Stock-based compensation	0	0	844	0	844
Net income	0	0	0	4,822	4,822
Dividend declared on common stock - $0.08 per share	$ 0	$ 0	0	(2,424)	(2,424)
Issuance of shares (in shares)	66,896	0
Issuance of shares	$ 1	$ 0	97	0	98
Acquisition of treasury stock (in shares)	0	(29,544)
Acquisition of treasury stock	$ 0	$ (189)	0	0	(189)
Balances (in shares) at Jan. 01, 2023	13,011,814	(2,894,242)
Balances at Jan. 01, 2023	$ 130	$ (15,803)	56,866	7,759	48,952
Balances (in shares) at Oct. 02, 2022	13,011,814	(2,894,242)
Balances at Oct. 02, 2022	$ 130	$ (15,803)	56,613	7,220	48,160
Stock-based compensation	0	0	253	0	253
Net income	0	0	0	1,348	1,348
Dividend declared on common stock - $0.08 per share	$ 0	$ 0	0	(809)	(809)
Balances (in shares) at Jan. 01, 2023	13,011,814	(2,894,242)
Balances at Jan. 01, 2023	$ 130	$ (15,803)	56,866	7,759	48,952
Balances (in shares) at Apr. 02, 2023	13,051,814	(2,897,507)
Balances at Apr. 02, 2023	$ 131	$ (15,821)	57,126	7,778	49,214
Stock-based compensation	0	0	573	0	573
Net income	0	0	0	3,890	3,890
Dividend declared on common stock - $0.08 per share	$ 0	$ 0	0	(2,452)	(2,452)
Issuance of shares (in shares)	86,412	0
Issuance of shares	$ 0	$ 0	0	0	0
Balances (in shares) at Dec. 31, 2023	13,138,226	(2,897,507)
Balances at Dec. 31, 2023	$ 131	$ (15,821)	57,699	9,216	51,225
Balances (in shares) at Oct. 01, 2023	13,138,226	(2,897,507)
Balances at Oct. 01, 2023	$ 131	$ (15,821)	57,509	8,334	50,153
Stock-based compensation	0	0	190	0	190
Net income	0	0	0	1,702	1,702
Dividend declared on common stock - $0.08 per share	$ 0	$ 0	0	(820)	(820)
Balances (in shares) at Dec. 31, 2023	13,138,226	(2,897,507)
Balances at Dec. 31, 2023	$ 131	$ (15,821)	$ 57,699	$ 9,216	$ 51,225

Unaudited Condensed Consolidated Statements of Changes In Shareholders' Equity (Parentheticals) - $ / shares	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Jan. 01, 2023	Dec. 31, 2023	Jan. 01, 2023
Dividends declared, per share (in dollars per share)	$ 0.08	$ 0.08	$ 0.24	$ 0.24

Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Jan. 01, 2023	Dec. 31, 2023	Jan. 01, 2023	Jan. 01, 2023
Operating activities:
Net income	$ 1,702	$ 1,348	$ 3,890	$ 4,822	$ 4,822
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation of property, plant and equipment			647		499
Amortization of intangibles	152	120	451		361
Amortization of right of use assets			3,208		1,330
Deferred income taxes			(1,106)		195
Gain on insurance proceeds received for damage to equipment	0	0	0	(34)	(34)
Gain on sale of property, plant and equipment	(58)	0	(58)	(2)	(2)
Reserve for unrecognized tax liabilities			56		98
Stock-based compensation			573		844
Changes in assets and liabilities:
Accounts receivable			765		4,352
Inventories			(1,112)		(5,129)
Prepaid expenses			(1,130)		(470)
Other assets			(14)		2
Lease liabilities			(2,497)		(1,461)
Accounts payable			(113)		(39)
Accrued liabilities			542		(998)
Net cash provided by operating activities			4,102		4,370
Cash used in investing activities:
Capital expenditures for property, plant and equipment			(662)		(399)
Insurance proceeds received for damage to equpment			0		34
Proceeds from sale of property, plant and equipment			105		2
Aggregate adjustment from the Manhattan and MTE acquisition			488		0
Net cash used in investing activities			(69)		(363)
Financing activities:
Repayments under revolving line of credit			(55,099)		0
Borrowings under revolving line of credit			52,440		0
Purchase of treasury stock from related parties			0		(189)
Issuance of common stock			0		98
Dividends paid			(2,433)		(2,438)
Net cash used in financing activities			(5,092)		(2,529)
Net (decrease) increase in cash and cash equivalents			(1,059)		1,478
Cash and cash equivalents at beginning of period			1,742		1,598
Cash and cash equivalents at end of period	683	3,076	683	3,076	3,076
Supplemental cash flow information:
Income taxes paid			1,628		130
Interest paid			650		7
Noncash activities:
Property, plant and equipment purchased but unpaid			(9)		(55)
Dividends declared but unpaid	$ (833)	$ (813)	$ (833)	$ (813)	$ (813)

Note 1 - Interim Financial Statements

9 Months Ended

Dec. 31, 2023

Notes to Financial Statements

Significant Accounting Policies [Text Block]

Note 1 – Interim Financial Statements

Note 2 - Advertising Costs

9 Months Ended

Dec. 31, 2023

Notes to Financial Statements

Advertising Costs [Text Block]

Note 2 – Advertising Costs

Note 3 - Segment and Related Information

9 Months Ended

Dec. 31, 2023

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

Note 3 – Segment and Related Information

	Three-Month Periods Ended				Nine-Month Periods Ended
	December 31, 2023		January 1, 2023		December 31, 2023		January 1, 2023
Bedding, blankets and accessories	$	8,996	$	9,005	$	24,345	$	26,006
Bibs, toys and disposable products		14,805		9,999		40,708		27,434
Total net sales	$	23,801	$	19,004	$	65,053	$	53,440

Note 4 - Licensing Agreements

9 Months Ended

Dec. 31, 2023

Notes to Financial Statements

Licensing Agreements [Text Block]

Note 4 – Licensing Agreements

Note 5 - Income Taxes

9 Months Ended

Dec. 31, 2023

Notes to Financial Statements

Income Tax Disclosure [Text Block]

Note 5 – Income Taxes

Note 6 - Inventories

9 Months Ended

Dec. 31, 2023

Notes to Financial Statements

Inventory Disclosure [Text Block]

Note 6 – Inventories

As of December 31, 2023 and April 2, 2023, the Company’s balances of inventory were $34.9 million and $34.2 million, respectively, nearly all of which were finished goods.

Note 7 - Acquisition

9 Months Ended

Dec. 31, 2023

Notes to Financial Statements

Business Combination Disclosure [Text Block]

Note 7 – Acquisition

Tangible assets:
Cash and cash equivalents	$	1,270
Accounts receivable		3,113
Inventories		12,578
Prepaid expenses		350
Other assets		91
Operating lease right of use assets		1,009
Property, plant and equipment		194
Total tangible assets		18,605
Amortizable intangible assets:
Tradename		300
Licensing relationships		200
Customer relationships		800
Total amortizable intangible assets		1,300
Goodwill		749
Total acquired assets		20,654

Liabilities assumed:
Accounts payable		2,048
Accrued wages and benefits		370
Operating lease liabilities, current		226
Other accrued liabilities		308
Operating lease liabilities, noncurrent		783
Total liabilities assumed		3,735
Net acquisition cost	$	16,919

Amount of goodwill recognized based upon the preliminary allocation of the acquisition cost	$	787,000
Adjustments made during the nine-month period ended December 31, 2023:
Settlement of the Aggregate Adjustment		(488,000	)
Resolution of pre-acquisition accounts receivable		(1,000	)
Revaluation of inventory as of the Closing Date		387,000
Resolution of pre-acquisition accounts payable		64,000
Net adjustments made during the nine-month period ended December 31, 2023		(38,000	)

Amount of goodwill recognized as of December 31, 2023	$	749,000

Note 8 - Financing Arrangements

9 Months Ended

Dec. 31, 2023

Notes to Financial Statements

Debt Disclosure [Text Block]

Note 8 – Financing Arrangements

Note 9 - Goodwill

9 Months Ended

Dec. 31, 2023

Notes to Financial Statements

Goodwill Disclosure [Text Block]

Note 9 – Goodwill

Note 10 - Other Intangible Assets

9 Months Ended

Dec. 31, 2023

Notes to Financial Statements

Intangible Assets Disclosure [Text Block]

Note 10 – Other Intangible Assets

									Amortization Expense
	Gross Amount				Accumulated Amortization				Three-Month Periods Ended				Nine-Month Periods Ended
	*December 31,*		*April 2,*		*December 31,*		*April 2,*		*December 31,*		*January 1,*		*December 31,*		*January 1,*
	*2023*		*2023*		*2023*		*2023*		*2023*		*2023*		*2023*		*2023*
Tradename and trademarks	$	2,867	$	2,867	$	2,145	$	2,025	$	42	$	35	$	120	$	105
Non-compete covenants		98		98		98		98		-		-		-		-
Patents		1,601		1,601		1,094		1,055		13		13		39		39
Customer relationships		8,174		8,174		6,566		6,289		92		72		277		217
Licensing relationships		200		200		15		-		5		-		15		-
Total other intangible assets	$	12,940	$	12,940	$	9,918	$	9,467	$	152	$	120	$	451	$	361

Note 11 - Leases

9 Months Ended

Dec. 31, 2023

Notes to Financial Statements

Lessee, Operating Leases [Text Block]

Note 11 – Leases

	Three-Month Periods Ended				Nine-Month Periods Ended
	December 31, 2023		January 1, 2023		December 31, 2023		January 1, 2023
Cost of products sold	$	1,037	$	403	$	2,917	$	1,205
Marketing and administrative expenses		97		43		291		125
Total operating lease costs	$	1,134	$	446	$	3,208	$	1,330

The maturities of the Company’s operating lease liabilities as of December 31, 2023 are as follows (in thousands):

Fiscal Year
2024	$	1,073
2025		4,408
2026		4,510
2027		4,189
2028		3,952
2029		663
Total undiscounted operating lease payments		18,795
Less imputed interest		2,259
Operating lease liabilities - net	$	16,536

Note 12 - Stock-based Compensation

9 Months Ended

Dec. 31, 2023

Notes to Financial Statements

Share-Based Payment Arrangement [Text Block]

Note 12 – Stock-based Compensation

Stock Options: The following table represents stock option activity for the nine-month periods ended December 31, 2023 and January 1, 2023:

	Nine-Month Periods Ended
	December 31, 2023					January 1, 2023
	Weighted-					Weighted-
	Average		Number of			Average		Number of
	Exercise		Options			Exercise		Options
	Price		Outstanding			Price		Outstanding
Outstanding at Beginning of Period	$	7.32		735,500		$	7.39		635,500
Granted		5.18		130,000			6.54		120,000
Exercised		-		-			4.92		(20,000	)
Expired		6.14		(10,000	)		-		-
Outstanding at End of Period		7.01		855,500			7.32		735,500
Exercisable at End of Period		7.41		665,500			7.42		499,000

	Nine-Month Periods Ended
	December 31, 2023						January 1, 2023
Number of options issued		10,000			120,000			120,000
Grant date	November 14, 2023			June 21, 2023			June 7, 2022
Dividend yield		7.60	%		6.08	%		4.89	%
Expected volatility		20.00	%		25.00	%		30.00	%
Risk free interest rate		4.56	%		4.29	%		2.95	%
Contractual term (years)		10.00			10.00			10.00
Expected term (years)		3.00			3.00			4.00
Forfeiture rate		5.00	%		5.00	%		5.00	%
Exercise price (grant-date closing price) per option	$	4.21		$	5.26		$	6.54
Fair value per option	$	0.20		$	0.46		$	0.90

	Three-Month Period Ended December 31, 2023						Three-Month Period Ended January 1, 2023
	Cost of		Marketing &				Cost of		Marketing &
	Products		Administrative		Total		Products		Administrative		Total
Options Granted in Fiscal Year	Sold		Expenses		Expense		Sold		Expenses		Expense
2021	$	-	$	-	$	-	$	-	$	11	$	11
2022		-		-		-		9		20		29
2023		5		7		12		6		7		13
2024		3		4		7		-		-		-

Total stock option compensation	$	8	$	11	$	19	$	15	$	38	$	53

	Nine-Month Period Ended December 31, 2023						Nine-Month Period Ended January 1, 2023
	Cost of		Marketing &				Cost of		Marketing &
	Products		Administrative		Total		Products		Administrative		Total
Options Granted in Fiscal Year	Sold		Expenses		Expense		Sold		Expenses		Expense
2021	$	-	$	-	$	-	$	3	$	37	$	40
2022		10		21		31		31		66		97
2023		17		24		41		12		17		29
2024		6		8		14		-		-		-

Total stock option compensation	$	33	$	53	$	86	$	46	$	120	$	166

Non-vested Stock Granted to Directors: The following shares of non-vested stock were granted to the Company’s directors:

Number of Shares	Fair Value per Share		Grant Date	Vesting Period (Years)
60,412		$4.85	August 15, 2023	One
46,896		6.65	August 16, 2022	One
40,165		7.47	August 11, 2021	One
41,452		5.79	August 12, 2020	Two

The fair value of the non-vested stock granted to the Company’s directors was based on the closing price of the Company’s common stock on the date of each grant.

Non-vested Stock Granted to Employees: The following shares of non-vested stock were granted to certain of the Company’s employees:

Number of Shares	Fair Value per Share		Grant Date	Vesting Date
26,000		$4.77	August 14, 2023	August 14, 2024
40,000		5.85	March 21, 2023	March 21, 2025
25,000		7.98	June 9, 2021	June 9, 2022
10,000		7.60	February 22, 2021	February 22, 2023
20,000		4.92	June 10, 2020	June 10, 2022

	Three-Month Periods Ended				Nine-Month Periods Ended
Stock Granted in Fiscal Year	December 31, 2023		January 1, 2023		December 31, 2023		January 1, 2023
2021	$	-	$	9	$	-	$	76
2022		37		113		147		472
2023		23		78		160		130
2024		111		-		180		-

Total stock grant compensation	$	171	$	200	$	487	$	678

Note 13 - Subsequent Events

9 Months Ended

Dec. 31, 2023

Notes to Financial Statements

Subsequent Events [Text Block]

Note 13 – Subsequent Events

Insider Trading Arrangements	3 Months Ended	9 Months Ended
Insider Trading Arrangements	Dec. 31, 2023	Dec. 31, 2023
Insider Trading Arr Line Items
Material Terms of Trading Arrangement [Text Block]		ITEM 5. OTHER INFORMATION During the three-month period ended December 31, 2023, none of the Company’s directors or officers informed the Company of the adoption, modification or termination of a “Rule 10-b5-1 trading arrangement” or “non-Rule 10-b5-1 trading arrangement,” as those terms are defined in Item 408(a) of Regulation S-K.
Rule 10b5-1 Arrangement Adopted [Flag]	false
Non-Rule 10b5-1 Arrangement Adopted [Flag]	false
Rule 10b5-1 Arrangement Terminated [Flag]	false
Non-Rule 10b5-1 Arrangement Terminated [Flag]	false

Note 3 - Segment and Related Information (Tables)

9 Months Ended

Dec. 31, 2023

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

	Three-Month Periods Ended				Nine-Month Periods Ended
	December 31, 2023		January 1, 2023		December 31, 2023		January 1, 2023
Bedding, blankets and accessories	$	8,996	$	9,005	$	24,345	$	26,006
Bibs, toys and disposable products		14,805		9,999		40,708		27,434
Total net sales	$	23,801	$	19,004	$	65,053	$	53,440

Note 7 - Acquisition (Tables)

9 Months Ended

Dec. 31, 2023

Notes Tables

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]

Tangible assets:
Cash and cash equivalents	$	1,270
Accounts receivable		3,113
Inventories		12,578
Prepaid expenses		350
Other assets		91
Operating lease right of use assets		1,009
Property, plant and equipment		194
Total tangible assets		18,605
Amortizable intangible assets:
Tradename		300
Licensing relationships		200
Customer relationships		800
Total amortizable intangible assets		1,300
Goodwill		749
Total acquired assets		20,654

Liabilities assumed:
Accounts payable		2,048
Accrued wages and benefits		370
Operating lease liabilities, current		226
Other accrued liabilities		308
Operating lease liabilities, noncurrent		783
Total liabilities assumed		3,735
Net acquisition cost	$	16,919

Business Combination, Segment Allocation [Table Text Block]

Amount of goodwill recognized based upon the preliminary allocation of the acquisition cost	$	787,000
Adjustments made during the nine-month period ended December 31, 2023:
Settlement of the Aggregate Adjustment		(488,000	)
Resolution of pre-acquisition accounts receivable		(1,000	)
Revaluation of inventory as of the Closing Date		387,000
Resolution of pre-acquisition accounts payable		64,000
Net adjustments made during the nine-month period ended December 31, 2023		(38,000	)

Amount of goodwill recognized as of December 31, 2023	$	749,000

Note 10 - Other Intangible Assets (Tables)

9 Months Ended

Dec. 31, 2023

Notes Tables

Schedule of Finite-Lived Intangible Assets [Table Text Block]

									Amortization Expense
	Gross Amount				Accumulated Amortization				Three-Month Periods Ended				Nine-Month Periods Ended
	*December 31,*		*April 2,*		*December 31,*		*April 2,*		*December 31,*		*January 1,*		*December 31,*		*January 1,*
	*2023*		*2023*		*2023*		*2023*		*2023*		*2023*		*2023*		*2023*
Tradename and trademarks	$	2,867	$	2,867	$	2,145	$	2,025	$	42	$	35	$	120	$	105
Non-compete covenants		98		98		98		98		-		-		-		-
Patents		1,601		1,601		1,094		1,055		13		13		39		39
Customer relationships		8,174		8,174		6,566		6,289		92		72		277		217
Licensing relationships		200		200		15		-		5		-		15		-
Total other intangible assets	$	12,940	$	12,940	$	9,918	$	9,467	$	152	$	120	$	451	$	361

Note 11 - Leases (Tables)

9 Months Ended

Dec. 31, 2023

Notes Tables

Lease, Cost [Table Text Block]

	Three-Month Periods Ended				Nine-Month Periods Ended
	December 31, 2023		January 1, 2023		December 31, 2023		January 1, 2023
Cost of products sold	$	1,037	$	403	$	2,917	$	1,205
Marketing and administrative expenses		97		43		291		125
Total operating lease costs	$	1,134	$	446	$	3,208	$	1,330

Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]

Fiscal Year
2024	$	1,073
2025		4,408
2026		4,510
2027		4,189
2028		3,952
2029		663
Total undiscounted operating lease payments		18,795
Less imputed interest		2,259
Operating lease liabilities - net	$	16,536

Note 12 - Stock-based Compensation (Tables)

9 Months Ended

Dec. 31, 2023

Notes Tables

Share-Based Payment Arrangement, Option, Activity [Table Text Block]

	Nine-Month Periods Ended
	December 31, 2023					January 1, 2023
	Weighted-					Weighted-
	Average		Number of			Average		Number of
	Exercise		Options			Exercise		Options
	Price		Outstanding			Price		Outstanding
Outstanding at Beginning of Period	$	7.32		735,500		$	7.39		635,500
Granted		5.18		130,000			6.54		120,000
Exercised		-		-			4.92		(20,000	)
Expired		6.14		(10,000	)		-		-
Outstanding at End of Period		7.01		855,500			7.32		735,500
Exercisable at End of Period		7.41		665,500			7.42		499,000

Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

	Nine-Month Periods Ended
	December 31, 2023						January 1, 2023
Number of options issued		10,000			120,000			120,000
Grant date	November 14, 2023			June 21, 2023			June 7, 2022
Dividend yield		7.60	%		6.08	%		4.89	%
Expected volatility		20.00	%		25.00	%		30.00	%
Risk free interest rate		4.56	%		4.29	%		2.95	%
Contractual term (years)		10.00			10.00			10.00
Expected term (years)		3.00			3.00			4.00
Forfeiture rate		5.00	%		5.00	%		5.00	%
Exercise price (grant-date closing price) per option	$	4.21		$	5.26		$	6.54
Fair value per option	$	0.20		$	0.46		$	0.90

Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]

	Three-Month Period Ended December 31, 2023						Three-Month Period Ended January 1, 2023
	Cost of		Marketing &				Cost of		Marketing &
	Products		Administrative		Total		Products		Administrative		Total
Options Granted in Fiscal Year	Sold		Expenses		Expense		Sold		Expenses		Expense
2021	$	-	$	-	$	-	$	-	$	11	$	11
2022		-		-		-		9		20		29
2023		5		7		12		6		7		13
2024		3		4		7		-		-		-

Total stock option compensation	$	8	$	11	$	19	$	15	$	38	$	53

	Nine-Month Period Ended December 31, 2023						Nine-Month Period Ended January 1, 2023
	Cost of		Marketing &				Cost of		Marketing &
	Products		Administrative		Total		Products		Administrative		Total
Options Granted in Fiscal Year	Sold		Expenses		Expense		Sold		Expenses		Expense
2021	$	-	$	-	$	-	$	3	$	37	$	40
2022		10		21		31		31		66		97
2023		17		24		41		12		17		29
2024		6		8		14		-		-		-

Total stock option compensation	$	33	$	53	$	86	$	46	$	120	$	166

	Three-Month Periods Ended				Nine-Month Periods Ended
Stock Granted in Fiscal Year	December 31, 2023		January 1, 2023		December 31, 2023		January 1, 2023
2021	$	-	$	9	$	-	$	76
2022		37		113		147		472
2023		23		78		160		130
2024		111		-		180		-

Total stock grant compensation	$	171	$	200	$	487	$	678

Schedule of Nonvested Share Activity [Table Text Block]

Number of Shares	Fair Value per Share		Grant Date	Vesting Period (Years)
60,412		$4.85	August 15, 2023	One
46,896		6.65	August 16, 2022	One
40,165		7.47	August 11, 2021	One
41,452		5.79	August 12, 2020	Two

Number of Shares	Fair Value per Share		Grant Date	Vesting Date
26,000		$4.77	August 14, 2023	August 14, 2024
40,000		5.85	March 21, 2023	March 21, 2025
25,000		7.98	June 9, 2021	June 9, 2022
10,000		7.60	February 22, 2021	February 22, 2023
20,000		4.92	June 10, 2020	June 10, 2022

Note 2 - Advertising Costs (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
Note 2 - Advertising Costs (Details Textual) - USD ($)	Dec. 31, 2023	Jan. 01, 2023	Dec. 31, 2023	Jan. 01, 2023
Advertising Expense	$ 267,000	$ 123,000	$ 631,000	$ 370,000

Note 3 - Segment and Related Information (Details Textual)	3 Months Ended
	Dec. 31, 2023
Number of Operating Segments	1

Note 3 - Segment and Related Information - Segment and Related Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Jan. 01, 2023	Dec. 31, 2023	Jan. 01, 2023
Net sales	$ 23,801	$ 19,004	$ 65,053	$ 53,440
Bedding, Blankets, And Accessories [Member]
Net sales	8,996	9,005	24,345	26,006
Bibs, Bath, Developmental Toy, Feeding, Baby Care and Disposable Products [Member]
Net sales	$ 14,805	$ 9,999	$ 40,708	$ 27,434

Note 4 - Licensing Agreements (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Jan. 01, 2023	Dec. 31, 2023	Jan. 01, 2023
Cost of Goods and Services Sold	$ 17,367	$ 14,498	$ 47,281	$ 38,335
Royalty [Member]
Cost of Goods and Services Sold	$ 1,300	$ 1,200	$ 3,800	$ 3,500

Note 5 - Income Taxes (Details Textual)	May 30, 2023 USD ($)
Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority	$ (442,000)
Income Tax Examination, Increase (Decrease) in Interest Expense	$ (86,000)

Note 6 - Inventories (Details Textual) - USD ($) $ in Thousands	Dec. 31, 2023	Apr. 02, 2023
Inventory, Net	$ 34,935	$ 34,211

Note 7 - Acquisition (Details Textual) - USD ($)		3 Months Ended		9 Months Ended
Note 7 - Acquisition (Details Textual) - USD ($)	Mar. 17, 2023	Dec. 31, 2023	Jan. 01, 2023	Dec. 31, 2023	Dec. 31, 2023	Jan. 01, 2023	Jan. 01, 2023	Sep. 29, 2023	Apr. 02, 2023
Goodwill		$ 7,874,000		$ 7,874,000	$ 7,874,000				$ 7,912,000
Amortization of Intangible Assets		152,000	$ 120,000		451,000		$ 361,000
Manhattan Acquisition [Member]
Business Combination, Consideration Transferred	$ 17,000,000
Business Combination, Net Working Capital Adjustments	13,750,000
Business Combination, Aggregate Adjustment of Purchase Price, Amount Received								$ 509,000
Business Combination, Aggregate Adjustment of Purchase Price, Amount Received, Interest Income								21,000
Business Combination, Consideration Transferred, Including Net Working Capital Adjustment	17,400,000
Business Combination, Aggregate Adjustment of Purchase Price, Acquisition Cost								$ 16,900,000
Goodwill	$ 749,000	749,000		749,000	749,000				$ 787,000
Amortization of Intangible Assets					$ 32,000	$ 90,000
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life (Year)	11 years
Business Acquisition, Pro Forma Revenue			26,000,000			74,500,000
Business Acquisition, Pro Forma Net Income (Loss)			$ 646,000			$ 2,700,000
Manhattan Acquisition [Member] \| Trade Names [Member]
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life (Year)	15 years
Manhattan Acquisition [Member] \| Customer and Licensing Relationships [Member]
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life (Year)	10 years
Manhattan Acquisition [Member] \| Developmental Toy, Feeding and Baby Care Products [Member]
Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual		$ 6,000,000		$ 14,500,000

Note 7 - Acquisition - Estimated Fair Value of Identifiable Net Assets (Details) - USD ($)	Dec. 31, 2023	Apr. 02, 2023	Mar. 17, 2023
Goodwill	$ 7,874,000	$ 7,912,000
Manhattan Acquisition [Member]
Cash and cash equivalents			$ 1,270,000
Accounts receivable			3,113,000
Inventories			12,578,000
Prepaid expenses			350,000
Other assets			91,000
Operating lease right of use assets			1,009,000
Property, plant and equipment			194,000
Total tangible assets			18,605,000
Amortizable intangible assets:			1,300,000
Goodwill	$ 749,000	$ 787,000	749,000
Total acquired assets			20,654,000
Accounts payable			2,048,000
Accrued wages and benefits			370,000
Operating lease liabilities, current			226,000
Other accrued liabilities			308,000
Operating lease liabilities, noncurrent			783,000
Total liabilities assumed			3,735,000
Net acquisition cost			16,919,000
Manhattan Acquisition [Member] \| Trade Names [Member]
Amortizable intangible assets:			300,000
Manhattan Acquisition [Member] \| Licensing Agreements [Member]
Amortizable intangible assets:			200,000
Manhattan Acquisition [Member] \| Customer Relationships [Member]
Amortizable intangible assets:			$ 800,000

Note 7 - Acquisition - Goodwill Adjustments (Details)	9 Months Ended
Note 7 - Acquisition - Goodwill Adjustments (Details)	Dec. 31, 2023 USD ($)
Amount of goodwill recognized based upon the preliminary allocation of the acquisition cost	$ 7,912,000
Amount of goodwill recognized as of December 31, 2023	7,874,000
Manhattan Acquisition [Member]
Amount of goodwill recognized based upon the preliminary allocation of the acquisition cost	787,000
Settlement of the Aggregate Adjustment	(488,000)
Resolution of pre-acquisition accounts receivable	(1,000)
Revaluation of inventory as of the Closing Date	387,000
Resolution of pre-acquisition accounts payable	64,000
Net adjustments made during the nine-month period ended December 31, 2023	(38,000)
Amount of goodwill recognized as of December 31, 2023	$ 749,000

Note 8 - Financing Arrangements (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Jan. 01, 2023	Dec. 31, 2023	Jan. 01, 2023	Jul. 02, 2023	Apr. 02, 2023
Selling, General and Administrative Expense	$ 4,107,000	$ 2,742,000	$ 12,189,000	$ 8,891,000
Long-Term Line of Credit	10,000,000		10,000,000			$ 12,700,000
Letters of Credit Outstanding, Amount	0		0			0
Line of Credit Facility, Remaining Borrowing Capacity	19,800,000		19,800,000			20,000,000
Accounts Receivable, after Allowance for Credit Loss, Current	22,000,000		22,000,000			22,800,000
Accounts Receivable, Allowance for Credit Loss, Current	2,500,000		2,500,000			1,500,000
Receivable Due from Factor [Member]
Accounts Receivable, Allowance for Credit Loss, Current	17,600,000		17,600,000			$ 20,700,000
Revolving Credit Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 35,000,000		$ 35,000,000
Revolving Credit Facility [Member] \| Prime Rate [Member]
Debt Instrument Basis Spread Below Variable Rate			0.50%
Debt Instrument, Interest Received on Daily Negative Balances, Basis Spread Below Variable Rate			2.00%
Revolving Credit Facility [Member] \| Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]
Debt Instrument, Basis Spread on Variable Rate			1.60%
Debt Instrument, Interest Rate, Effective Percentage	6.90%		6.90%
Letter of Credit [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 1,500,000		$ 1,500,000
Factoring Agreements [Member]
Long-Term Debt					$ 0
Factoring Fees [Member]
Selling, General and Administrative Expense	$ 106,000	$ 77,000	$ 265,000	$ 224,000

Note 9 - Goodwill (Details Textual) - USD ($) $ in Thousands	Dec. 31, 2023	Apr. 02, 2023
Goodwill, Gross	$ 30,800	$ 30,800
Goodwill, Impaired, Accumulated Impairment Loss	22,900	22,900
Goodwill	$ 7,874	$ 7,912

Note 10 - Other Intangible Assets - Other Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Jan. 01, 2023	Dec. 31, 2023	Jan. 01, 2023	Apr. 02, 2023
Finite-lived intangible assets, gross amount	$ 12,940		$ 12,940		$ 12,940
Finite-lived intangible assets, accumulated amortization	9,918		9,918		9,467
Amortization expense	152	$ 120	451	$ 361
Trademarks and Trade Names [Member]
Finite-lived intangible assets, gross amount	2,867		2,867		2,867
Finite-lived intangible assets, accumulated amortization	2,145		2,145		2,025
Amortization expense	42	35	120	105
Noncompete Agreements [Member]
Finite-lived intangible assets, gross amount	98		98		98
Finite-lived intangible assets, accumulated amortization	98		98		98
Amortization expense	0	0	0	0
Patents [Member]
Finite-lived intangible assets, gross amount	1,601		1,601		1,601
Finite-lived intangible assets, accumulated amortization	1,094		1,094		1,055
Amortization expense	13	13	39	39
Customer Relationships [Member]
Finite-lived intangible assets, gross amount	8,174		8,174		8,174
Finite-lived intangible assets, accumulated amortization	6,566		6,566		6,289
Amortization expense	92	72	277	217
Licensing Agreements [Member]
Finite-lived intangible assets, gross amount	200		200		200
Finite-lived intangible assets, accumulated amortization	15		15		$ 0
Amortization expense	$ 5	$ 0	$ 15	$ 0

Note 11 - Leases (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
Note 11 - Leases (Details Textual) - USD ($)	Dec. 31, 2023	Jan. 01, 2023	Dec. 31, 2023	Jan. 01, 2023	Apr. 02, 2023
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$ 959,000		$ 959,000
Operating Lease, Payments	1,100,000	$ 492,000	2,500,000	$ 1,500,000
Operating Lease, Right-of-Use Asset, Periodic Reduction	$ 254,000	$ 16,000	$ 757,000	$ 59,000
Operating Lease, Weighted Average Remaining Lease Term (Year)	4 years 2 months 12 days		4 years 2 months 12 days		5 years
Operating Lease, Weighted Average Discount Rate, Percent	6.00%		6.00%		5.90%

Note 11 - Leases - Classification of Operating Lease Costs in Consolidated Statements of Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Jan. 01, 2023	Dec. 31, 2023	Jan. 01, 2023
Operating Lease Costs	$ 1,134	$ 446	$ 3,208	$ 1,330
Cost of Sales [Member]
Operating Lease Costs	1,037	403	2,917	1,205
Selling, General and Administrative Expenses [Member]
Operating Lease Costs	$ 97	$ 43	$ 291	$ 125

Note 11 - Leases - Maturities of Operating Lease Liabilities (Details) $ in Thousands	Dec. 31, 2023 USD ($)
2024	$ 1,073
2025	4,408
2026	4,510
2027	4,189
2028	3,952
2029	663
Total undiscounted operating lease payments	18,795
Less imputed interest	2,259
Operating lease liabilities - net	$ 16,536

Note 12 - Stock-based Compensation (Details Textual) - USD ($)						1 Months Ended			3 Months Ended		6 Months Ended	9 Months Ended
	Feb. 21, 2023	Aug. 16, 2022	May 01, 2022	Mar. 01, 2022	Aug. 11, 2021	Aug. 31, 2023	Aug. 31, 2022	Jun. 30, 2022	Dec. 31, 2023	Jan. 01, 2023	Oct. 02, 2022	Dec. 31, 2023	Jan. 01, 2023
Common Stock, Capital Shares Reserved for Future Issuance (in shares)									549,000			549,000
Share-Based Payment Arrangement, Expense									$ 190,000	$ 253,000		$ 573,000	$ 844,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value									19,000				28,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value									$ 11,000			11,000
Proceeds from Stock Options Exercised										0		0
Payment, Tax Withholding, Share-Based Payment Arrangement											$ 10,000
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Month)									6 months 24 days
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount									$ 491,000			491,000
Share-Based Payment Arrangement, Option [Member]
Share-Based Payment Arrangement, Expense									19,000	$ 53,000		$ 86,000	$ 166,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)												2 years	2 years
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount									$ 69,000			$ 69,000
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Month)									9 months 27 days
Non-vested Stock Grants [Member] \| Former Chairman, President and Chief Executive Officer [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)					8,033
Non-vested Stock Grants [Member] \| Non Employee Directors [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Accelerated Vesting, Number (in shares)			8,033
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested			$ 50,000			$ 168,000	$ 331,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares)						35,172	52,856
Non-vested Stock Grants [Member] \| Director [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)		11,724
Share-Based Compensation Arrangement by Share-Based Payment Award, Accelerated Vesting, Number (in shares)	11,724
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested	$ 67,000
Non-vested Stock Grants [Member] \| Employee [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested								$ 293,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares)								45,000
Performance Shares [Member]
Share Based Compensation Arrangement By Share Based Payment Award Equity Instrument Other Than Options Grants In Period Total Grant Date Fair Value				$ 732,000
Performance Shares [Member] \| Executive Officer [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)				187,500
Performance Shares [Member] \| Executive Officer [Member] \| Share-Based Payment Arrangement, Tranche One [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)				75,000
Share Based Compensation, Grant Conditions, Minimum Per-Share Price (in dollars per share)				$ 8
Share Based Compensation, Grant Conditions, Trading Period (Day)				10 days
Performance Shares [Member] \| Executive Officer [Member] \| Share-Based Payment Arrangement, Tranche Two [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)				112,500
Share Based Compensation, Grant Conditions, Minimum Per-Share Price (in dollars per share)				$ 9
Share Based Compensation, Grant Conditions, Trading Period (Day)				10 days

Note 12 - Stock-based Compensation - Stock Option Activity (Details) - $ / shares	9 Months Ended
	Dec. 31, 2023	Jan. 01, 2023
Outstanding, Weighted-average exercise price, beginning balance (in dollars per share)	$ 7.32	$ 7.39
Outstanding, Shares, beginning balance (in shares)	735,500	635,500
Granted, Weighted-average exercise price (in dollars per share)	$ 5.18	$ 6.54
Number of options issued (in shares)	130,000	120,000
Exercised, Weighted-average exercise price (in dollars per share)	$ 0	$ 4.92
Exercised, Shares (in shares)	0	(20,000)
Expired, Weighted-average exercise price (in dollars per share)	$ 6.14	$ 0
Expired, Shares (in shares)	(10,000)	0
Outstanding, Weighted-average exercise price, ending balance (in dollars per share)	$ 7.01	$ 7.32
Outstanding, Shares, ending balance (in shares)	855,500	735,500
Exercisable, Weighted-average exercise price (in dollars per share)	$ 7.41	$ 7.42
Exercisable, Shares (in shares)	665,500	499,000

Note 12 - Stock-based Compensation - Estimated Fair Value of Stock Options Assumptions (Details) - $ / shares	9 Months Ended
	Dec. 31, 2023	Jan. 01, 2023
Number of options issued (in shares)	130,000	120,000
June 7, 2022 [Member]
Number of options issued (in shares)	10,000
Grant date	Nov. 14, 2023
Dividend yield	7.60%
Expected volatility	20.00%
Risk free interest rate	4.56%
Contractual term (years) (Year)	10 years
Expected term (years) (Year)	3 years
Forfeiture rate	5.00%
Exercise price (grant-date closing price) per option (in dollars per share)	$ 4.21
Fair value per option (in dollars per share)	$ 0.2
June 9, 2021 [Member]
Number of options issued (in shares)	120,000	120,000
Grant date	Jun. 21, 2023	Jun. 07, 2022
Dividend yield	6.08%	4.89%
Expected volatility	25.00%	30.00%
Risk free interest rate	4.29%	2.95%
Contractual term (years) (Year)	10 years	10 years
Expected term (years) (Year)	3 years	4 years
Forfeiture rate	5.00%	5.00%
Exercise price (grant-date closing price) per option (in dollars per share)	$ 5.26	$ 6.54
Fair value per option (in dollars per share)	$ 0.46	$ 0.9

Note 12 - Stock-based Compensation - Stock Option Compensation (Details) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Jan. 01, 2023	Dec. 31, 2023	Jan. 01, 2023
Allocated Share Based Compensation Expense	$ 190,000	$ 253,000	$ 573,000	$ 844,000
Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	19,000	53,000	86,000	166,000
Fiscal Year 2021 [Member] \| Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	0	11,000	0	40,000
Fiscal Year 2022 [Member] \| Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	0	29,000	31,000	97,000
Fiscal Year 2023 [Member] \| Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	12,000	13,000	41,000	29,000
Fiscal Year 2024 [Member] \| Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	7,000	0	14,000	0
Cost of Sales [Member] \| Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	8,000	15,000	33,000	46,000
Cost of Sales [Member] \| Fiscal Year 2021 [Member] \| Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	0	0	0	3,000
Cost of Sales [Member] \| Fiscal Year 2022 [Member] \| Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	0	9,000	10,000	31,000
Cost of Sales [Member] \| Fiscal Year 2023 [Member] \| Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	5,000	6,000	17,000	12,000
Cost of Sales [Member] \| Fiscal Year 2024 [Member] \| Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	3,000	0	6,000	0
Marketing and Administrative Expenses [Member] \| Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	11,000	38,000	53,000	120,000
Marketing and Administrative Expenses [Member] \| Fiscal Year 2021 [Member] \| Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	0	11,000	0	37,000
Marketing and Administrative Expenses [Member] \| Fiscal Year 2022 [Member] \| Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	0	20,000	21,000	66,000
Marketing and Administrative Expenses [Member] \| Fiscal Year 2023 [Member] \| Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	7,000	7,000	24,000	17,000
Marketing and Administrative Expenses [Member] \| Fiscal Year 2024 [Member] \| Share-Based Payment Arrangement, Option [Member]
Allocated Share Based Compensation Expense	4,000	0	8,000	0
Selling, General and Administrative Expenses [Member] \| Non-vested Stock Grants [Member]
Allocated Share Based Compensation Expense	171,000	200,000	487,000	678,000
Selling, General and Administrative Expenses [Member] \| Fiscal Year 2021 [Member] \| Non-vested Stock Grants [Member]
Allocated Share Based Compensation Expense	0	9,000	0	76,000
Selling, General and Administrative Expenses [Member] \| Fiscal Year 2022 [Member] \| Non-vested Stock Grants [Member]
Allocated Share Based Compensation Expense	37,000	113,000	147,000	472,000
Selling, General and Administrative Expenses [Member] \| Fiscal Year 2023 [Member] \| Non-vested Stock Grants [Member]
Allocated Share Based Compensation Expense	23,000	78,000	160,000	130,000
Selling, General and Administrative Expenses [Member] \| Fiscal Year 2024 [Member] \| Non-vested Stock Grants [Member]
Allocated Share Based Compensation Expense	$ 111,000	$ 0	$ 180,000	$ 0

Note 12 - Stock-based Compensation - Non-vested Stock to Directors and Employees (Details) - Non-vested Stock Grants [Member]	9 Months Ended
	Dec. 31, 2023 $ / shares shares
August 14, 2023 [Member] \| Share-Based Payment Arrangement, Employee [Member]
Fair Value Per Share (in dollars per share) \| $ / shares	$ 4.77
Number of Shares (in shares) \| shares	26,000
March 21, 2023 [Member] \| Share-Based Payment Arrangement, Employee [Member]
Fair Value Per Share (in dollars per share) \| $ / shares	$ 5.85
Number of Shares (in shares) \| shares	40,000
June 9, 2021 [Member] \| Share-Based Payment Arrangement, Employee [Member]
Fair Value Per Share (in dollars per share) \| $ / shares	$ 7.98
Number of Shares (in shares) \| shares	25,000
February 22, 2021 [Member] \| Share-Based Payment Arrangement, Employee [Member]
Fair Value Per Share (in dollars per share) \| $ / shares	$ 7.6
Number of Shares (in shares) \| shares	10,000
June 10, 2020 [Member] \| Share-Based Payment Arrangement, Employee [Member]
Fair Value Per Share (in dollars per share) \| $ / shares	$ 4.92
Number of Shares (in shares) \| shares	20,000
Non Employee Directors [Member] \| August 15, 2023 [Member]
Fair Value Per Share (in dollars per share) \| $ / shares	$ 4.85
Number of Shares (in shares) \| shares	60,412
Vesting Period (Year)	1 year
Non Employee Directors [Member] \| August 16, 2022 [Member]
Fair Value Per Share (in dollars per share) \| $ / shares	$ 6.65
Number of Shares (in shares) \| shares	46,896
Vesting Period (Year)	1 year
Non Employee Directors [Member] \| August 11, 2021 [Member]
Fair Value Per Share (in dollars per share) \| $ / shares	$ 7.47
Number of Shares (in shares) \| shares	40,165
Vesting Period (Year)	1 year
Non Employee Directors [Member] \| August 12, 2020 [Member]
Fair Value Per Share (in dollars per share) \| $ / shares	$ 5.79
Number of Shares (in shares) \| shares	41,452
Vesting Period (Year)	2 years